Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.487655901722459e-57,56.078719397363464,7275.990637632097,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.2707538862715643e-54,0,0,78
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.4021528450288543e-25,10.424749163879598,590.9609115820529,"['COX7B', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'UCP3', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1']",6.077446697923002e-23,0,0,54
3,Oxidative phosphorylation WP623,9.52175084729006e-15,9.76064942212438,315.1244957903952,"['NDUFB9', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1']",1.6060019762429232e-12,0,0,31
4,Nonalcoholic fatty liver disease WP4396,6.99058037959212e-12,3.875194552529183,99.54002030621592,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'COX4I1', 'PIK3CD', 'COX6A1', 'COX7C', 'LEPR', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CEBPA', 'NDUFB9', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",8.843084180184032e-10,0,0,49
5,Mitochondrial CIV Assembly WP4922,2.658189962057339e-09,9.148799259788872,180.64871740175153,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",2.690088241602027e-07,0,0,19
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.134003344070954e-07,4.919965576592083,75.57114323385134,"['NDUFB9', 'NDUFA8', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1']",1.7996761534998376e-05,0,0,22
7,Glycolysis and Gluconeogenesis WP534,2.5661762965754078e-06,6.244953627932351,80.39187251326204,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'ENO1', 'ENO2', 'GCK', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH']",0.00018549788658102234,0,0,15
8,Computational Model of Aerobic Glycolysis WP4629,0.00019429358989727448,10.891634980988593,93.08143947715092,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.01228906956100261,0,0,7
9,"GPCRs, Class A Rhodopsin-like WP455",0.00031120116252707973,2.643651529193698,21.34767387691338,"['GPR27', 'P2RY12', 'OXTR', 'GPR12', 'P2RY14', 'GPR87', 'GPR22', 'CHRM5', 'OPRL1', 'GPR83', 'ADRA1D', 'SSTR1', 'GPR6', 'MCHR1', 'SSTR3', 'HCRTR2', 'MAS1', 'FSHR', 'GPR171', 'ACKR4', 'OR6A2', 'OR3A2']",0.01749642091541137,0,0,22
10,Mitochondrial complex III assembly WP4921,0.00035191696336597713,7.114906832298137,56.57855954837307,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.017806998346318444,0,0,8
11,Selenium Micronutrient Network WP15,0.000496295976196248,3.1195414847161573,23.734526279687756,"['GPX4', 'DIO1', 'TXN', 'KMO', 'SELENOK', 'SELENOH', 'SOD1', 'PRDX3', 'SELENOM', 'PRDX5', 'SELENOS', 'RFK', 'PRDX1', 'SELENOW', 'SEPHS2', 'MSRB1']",0.022829614905027405,0,0,16
12,Myometrial relaxation and contraction pathways WP289,0.0011158065336214426,2.0606102253985705,14.00839466201312,"['RYR1', 'OXTR', 'RGS14', 'YWHAB', 'ITPR2', 'RXFP1', 'ETS2', 'ACTB', 'ACTG1', 'RGS4', 'GNG3', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP4', 'PRKCD', 'FOS', 'ACTA2', 'CREB3', 'PRKAR1A', 'PRKCQ', 'CALM3', 'PRKD1', 'CALM1', 'CALM2']",0.04704984216770416,0,0,29
13,Proximal tubule transport WP4917,0.0014021748220375313,3.3986928104575163,22.328496848139483,"['ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'SLC47A1', 'SLC7A9', 'SLC3A1', 'ATP1A1', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.05394578574424182,0,0,12
14,IL-18 signaling pathway WP4754,0.0014925711470738841,1.7891908975979773,11.642721493256605,"['CEBPB', 'NRN1', 'STOML1', 'CD81', 'MEPCE', 'COX17', 'ENO1', 'ACACB', 'FUT1', 'PTMS', 'TMSB4X', 'STMN1', 'TIMP3', 'FADD', 'RPS11', 'MAPK3', 'SLC12A3', 'JUN', 'TICAM2', 'USP5', 'IMP3', 'BAD', 'PRKCD', 'IL18', 'NDUFC1', 'FOS', 'BPGM', 'EEF2', 'ACTA2', 'NR4A1', 'ARL4D', 'CLDN4', 'NACA', 'CYCS', 'BAX', 'NFKBIE', 'CDK5R2', 'ITM2C', 'ARF6', 'MYH7']",0.05394578574424182,0,0,40
15,Glycolysis in senescence WP5049,0.0017541191951567895,7.463843648208469,47.36397267472365,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.05917228751662237,0,0,6
16,Exercise-induced Circadian Regulation WP410,0.002317442319573593,2.8148239349913813,17.078356349319282,"['DAZAP2', 'HSPA8', 'CEBPB', 'BTG1', 'GSTP1', 'GFRA1', 'HERPUD1', 'PER2', 'DNAJA1', 'SUMO1', 'STBD1', 'UCP3', 'SUMO3', 'EIF4G2']",0.07328911335651488,0,0,14
17,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0027208063712956627,1.4903243026825037,8.803087803871769,"['RPL5', 'ARPC5L', 'SHB', 'RPL10A', 'ELK1', 'RPL7', 'HERPUD1', 'ACTG1', 'RND1', 'TUBB8', 'RPL18A', 'TMSB4X', 'CFL1', 'RPLP2', 'SH3BGRL3', 'ELOC', 'ATP6V1E1', 'RPS11', 'IER5', 'TMSB10', 'HRAS', 'HSP90AA1', 'ANXA1', 'SSR4', 'PRKCD', 'RPS6', 'RPL13A', 'EPN1', 'VAV2', 'RCN1', 'KATNAL2', 'FSCN1', 'RPL27', 'PRKD1', 'RPL26', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'PTMA', 'FJX1', 'ARF6', 'LRRC59', 'SET', 'CRIP2', 'TXN', 'ACACB', 'NDRG1', 'FUT1', 'LDHA', 'AP2S1', 'PGK1', 'DNAJB9', 'FLNB', 'FADD', 'CCT7', 'ABCF2', 'MAPK3', 'EGR1', 'JUN', 'JAG1', 'SDF2L1', 'EGR3', 'NFATC2', 'DNAJA1', 'NR4A1', 'NR4A3', 'NOX4', 'CYCS', 'CALR', 'EIF4G2']",0.08098400140444738,0,0,70
18,Cellular Proteostasis WP4918,0.004397199499123903,12.429501084598698,67.45226009999995,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.12361016369759416,0,0,4
19,Cori Cycle WP1946,0.005082451688296646,5.330386226151698,28.154894922647145,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.13535371338305804,0,0,6
20,Transcriptional cascade regulating adipogenesis WP4211,0.0070432442098933516,6.216494845360825,30.806998896736403,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG']",0.1781940785103018,0,0,5
21,HIF1A and PPARG regulation of glycolysis WP2456,0.00913448283898228,8.285610990600144,38.90673278952252,"['LDHA', 'TPI1', 'PPARG', 'GAPDH']",0.22009753888214448,0,0,4
22,Vitamin D Receptor Pathway WP2877,0.009603624366432691,2.04,9.477054015719268,"['CDKN2D', 'CEBPA', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'GADD45A', 'CDKN2A', 'NFATC2', 'CYP3A5', 'CEACAM1', 'TNFSF4', 'CREG2', 'S100A6', 'TIMP2', 'TIMP3', 'SOSTDC1', 'PRKCQ']",0.2208833604279519,0,0,18
23,Peptide GPCRs WP24,0.012680953664310475,3.1103260869565217,13.584828556581256,"['OXTR', 'FSHR', 'OPRL1', 'TAC4', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2']",0.26873112477191047,0,0,8
24,Spinal Cord Injury WP2431,0.012746140305387057,1.9680759275237274,8.585783927782092,"['EGR1', 'CDKN1B', 'ANXA1', 'GADD45A', 'BDNF', 'XYLT1', 'MIF', 'FOS', 'RTN4', 'TNFSF13B', 'RHOB', 'SELP', 'NR4A1', 'ACAN', 'APEX1', 'NOX4', 'ROS1', 'MAPK3']",0.26873112477191047,0,0,18
25,Melanoma WP4685,0.015154044270866276,2.076195671940353,8.69819650876191,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PIK3CD', 'MITF', 'FOS', 'ELK1', 'BAX', 'CALM3', 'CALM1', 'HRAS', 'CALM2', 'MAPK3']",0.3067178560423334,0,0,15
26,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.017357596897466968,2.666278256816593,10.808358845003644,"['PRKCH', 'STAR', 'FSHR', 'PRKCD', 'PIK3CD', 'PRKCQ', 'HRAS', 'PLCB2', 'MAPK3']",0.32641255807180075,0,0,9
27,Galanin receptor pathway WP4970,0.01741727088525419,4.439578327261453,17.981592957177497,"['CDKN1A', 'CDKN1B', 'PRKCD', 'PPARG', 'FOS']",0.32641255807180075,0,0,5
28,Gastrin signaling pathway WP4659,0.018393484622755144,1.8065201534899946,7.218418753107746,"['EGR1', 'JUN', 'CDKN1A', 'PRKCH', 'JAG1', 'CDKN1B', 'CDKN2A', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'ELK1', 'RHOB', 'KAT5', 'PRKCQ', 'PPARG', 'PRKD1', 'HRAS', 'MEF2D', 'MAPK3']",0.3323965435397894,0,0,20
29,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.02147714359163112,9.317073170731707,35.78469783585851,"['COX8A', 'GSTP1', 'COX5A']",0.37473912611604643,0,0,3
30,TP53 network WP1742,0.025126547183757633,3.8842919153553987,14.309072387959347,"['CDKN1A', 'SUMO1', 'CDKN2A', 'GADD45A', 'BAX']",0.4238010958327121,0,0,5
31,Zinc homeostasis WP3529,0.029777899320718428,3.1080347448425623,10.921599265205346,"['SLC39A11', 'SLC30A1', 'SLC39A7', 'SLC30A10', 'SLC39A1', 'SLC39A3']",0.4860521631059202,0,0,6
32,Sleep regulation WP3591,0.0318421780682864,2.7200570342205324,9.375937352082175,"['CHRNB2', 'OXTR', 'AHCY', 'STAR', 'IL18', 'FOS', 'HCRTR2']",0.5035044407047787,0,0,7
33,Apoptosis Modulation and Signaling WP1772,0.034475078198087594,1.8309746157055293,6.165841050805918,"['JUN', 'ENDOG', 'CRADD', 'CDKN2A', 'BAD', 'FOS', 'CAPNS1', 'CASP6', 'PEA15', 'CYCS', 'BAX', 'PRKD1', 'FADD', 'BCL2L2', 'MAPK3']",0.5173116185448234,0,0,15
34,7q11.23 copy number variation syndrome WP4932,0.03476006923028458,1.6906037647426384,5.679221536336956,"['ATP5PB', 'H2AFX', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'NRG1', 'ACACB', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'GRIP1', 'CLDN4', 'ATP5F1B', 'CFL1', 'BCL7B', 'EIF4H', 'GAPDH', 'MAPK3']",0.5173116185448234,0,0,19
35,Metabolic reprogramming in colon cancer WP4290,0.03659445811409088,2.14494765674834,7.095183269121277,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'PYCR2', 'PDHB', 'ENO1', 'ALDOB', 'GAPDH']",0.5290513087351424,0,0,10
36,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.03855712384253023,6.210840108401084,20.220100500260536,"['HSD11B1', 'HSD11B2', 'STAR']",0.5419417962311194,0,0,3
37,Aryl Hydrocarbon Receptor Pathway WP2873,0.0397321028796406,2.559830015656453,8.256976899328109,"['HSP90AA1', 'JUN', 'CDKN1B', 'AIP', 'CYP1B1', 'AHRR', 'BAX']",0.5433633528945444,0,0,7
38,Complement system WP2806,0.0453631873351281,2.1525912912536076,6.658081866875072,"['SELP', 'PRNP', 'FKBP2', 'RPS19', 'F12', 'CD59', 'TXN', 'CALR', 'KLKB1']",0.5885582767070466,0,0,9
39,"GPCRs, Other WP117",0.0453631873351281,2.1525912912536076,6.658081866875072,"['ADGRV1', 'FSHR', 'GPR88', 'OR2M4', 'ADRA1D', 'GPR83', 'CELSR2', 'RXFP1', 'GPR135']",0.5885582767070466,0,0,9
40,Senescence and Autophagy in Cancer WP615,0.055590752186451674,1.6596797671033479,4.796040386470147,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'SPARC', 'CDKN1B', 'IGFBP5', 'CDKN2A', 'HMGA1', 'GABARAP', 'RSL1D1', 'MAP1LC3A', 'SLC39A1', 'HRAS', 'SLC39A3']",0.6765310857862664,0,0,16
41,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.05640176831363982,1.538471940500338,4.423498782189964,"['CHRNB2', 'EGR1', 'JUN', 'CEBPB', 'TSPYL1', 'BDNF', 'YWHAB', 'SSTR1', 'GCK', 'HSP90B1', 'NEUROD1', 'ADCYAP1', 'PRKAR1A', 'BHLHE40', 'PKNOX1', 'SCN3B', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAG', 'YWHAH']",0.6765310857862664,0,0,21
42,White fat cell differentiation WP4149,0.06058939810781786,2.4857763300760043,6.96921039101552,"['CEBPA', 'CEBPB', 'EGR2', 'DDIT3', 'PPARG', 'ZNF423']",0.6765310857862664,0,0,6
43,Dual hijack model of Vif in HIV infection WP3300,0.060624136548194235,4.657723577235773,13.055888768518829,"['ELOB', 'ELOC', 'RUNX1']",0.6765310857862664,0,0,3
44,NAD Biosynthesis II (from tryptophan) WP2485,0.060624136548194235,4.657723577235773,13.055888768518829,"['TDO2', 'NMNAT1', 'KMO']",0.6765310857862664,0,0,3
45,Pathways in clear cell renal cell carcinoma WP4018,0.06082344854664398,1.666764086976853,4.666572584550702,"['TPI1', 'BHLHE41', 'PLOD2', 'ENO1', 'ENO2', 'ACACB', 'TOX2', 'LDHA', 'PKM', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'KCNJ2']",0.6765310857862664,0,0,15
46,Pyrimidine metabolism WP4022,0.06150282598056968,1.6323287278974874,4.552029670187255,"['NME2', 'NME1', 'NT5C', 'POLE4', 'POLD4', 'POLD2', 'POLE3', 'POLR2E', 'CMPK2', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.6765310857862664,0,0,16
47,Prostaglandin Synthesis and Regulation WP98,0.07056831562480277,2.1752851711026615,5.767059536943983,"['HSD11B1', 'HSD11B2', 'ANXA1', 'S100A6', 'MITF', 'PPARG', 'PTGES']",0.7439076605447958,0,0,7
48,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.07056831562480277,2.1752851711026615,5.767059536943983,"['CREB3', 'STAR', 'ITPR2', 'CALM3', 'CALM1', 'PLCB2', 'CALM2']",0.7439076605447958,0,0,7
49,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.07301281225749146,3.105748373101952,8.128117247041066,"['CD63', 'CD81', 'ETS2', 'SOD1']",0.7488680465322055,0,0,4
50,Androgen receptor signaling pathway WP138,0.07457646601785818,1.5802315103625146,4.102170843709519,"['CDKN1A', 'JUN', 'LIMK2', 'DSTN', 'RNF6', 'PARK7', 'ETV5', 'RHOB', 'SUMO1', 'KAT5', 'PRDX1', 'BAG1', 'STUB1', 'CALR', 'FKBP4', 'RAN']",0.7488680465322055,0,0,16
51,Nanomaterial induced apoptosis WP2507,0.07547879520383889,2.58862362090794,6.688753687061133,"['ENDOG', 'CASP6', 'BAX', 'CYCS', 'FADD']",0.7488680465322055,0,0,5
52,Ferroptosis WP4313,0.07753044697852297,1.9890434782608695,5.086152358548046,"['PRNP', 'MAP1LC3A', 'GPX4', 'FTH1', 'PCBP1', 'ACSL5', 'SLC7A11', 'FTL']",0.7544308879063966,0,0,8
53,Alzheimer's disease WP2059,0.08171864229494528,1.6126661012157195,4.038878907320408,"['PSENEN', 'ATP5MD', 'BAD', 'ITPR2', 'LPL', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'PLCB2', 'GAPDH', 'CALM2', 'MAPK3', 'CDK5R1']",0.7801817547404211,0,0,14
54,Blood Clotting Cascade WP272,0.08723329217889397,3.7258536585365856,9.087987598969919,"['F8A1', 'F12', 'KLKB1']",0.791685210953279,0,0,3
55,Trans-sulfuration pathway WP2333,0.08723329217889397,3.7258536585365856,9.087987598969919,"['AHCY', 'GOT1', 'MAT2B']",0.791685210953279,0,0,3
56,Endometrial cancer WP4155,0.08916313461975586,1.658242556281772,4.0084491920419865,"['CDKN1A', 'GADD45B', 'BAD', 'GADD45A', 'PIK3CD', 'BAX', 'FOS', 'CTNNA2', 'FGF1', 'ELK1', 'HRAS', 'MAPK3']",0.791685210953279,0,0,12
57,Calcium Regulation in the Cardiac Cell WP536,0.08918193087813618,1.4264558232931728,3.447853317427477,"['RYR1', 'PRKCH', 'RGS14', 'YWHAB', 'CHRM5', 'PRKCD', 'ITPR2', 'ADRA1D', 'RGS4', 'SLC8A3', 'GNG3', 'PLN', 'PRKAR1A', 'PRKCQ', 'CALM3', 'PRKD1', 'CALR', 'CASQ1', 'CALM1', 'CALM2', 'YWHAG', 'YWHAH']",0.791685210953279,0,0,22
58,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.09305607446182186,2.3892900371467922,5.673495864590637,"['H3F3B', 'H2AFZ', 'H2AFX', 'DUSP6', 'MAPK3']",0.8118340289255492,0,0,5
59,miR-517 relationship with ARCN1 and USP1 WP3596,0.09533941683742587,6.208017334777898,14.59077730219812,"['CDKN1A', 'ARCN1']",0.8176566935548728,0,0,2
60,Photodynamic therapy-induced unfolded protein response WP3613,0.10509609726541079,2.070937386898299,4.6655737004435425,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1']",0.886310420271631,0,0,6
61,Base Excision Repair WP4752,0.11244215427048598,1.8910563729542074,4.132556455667659,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'APEX1', 'POLD2', 'POLE3']",0.9056355123805784,0,0,7
62,CAMKK2  Pathway WP4874,0.11244215427048598,1.8910563729542074,4.132556455667659,"['FIS1', 'MAP1LC3A', 'WFS1', 'NFATC2', 'CALM1', 'CALM2', 'MAPK3']",0.9056355123805784,0,0,7
63,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.11779122655823725,3.104607046070461,6.640262353987413,"['JUN', 'PRKCQ', 'MAPK3']",0.9056355123805784,0,0,3
64,Differentiation of white and brown adipocyte WP2895,0.11812637118007543,2.484164859002169,5.306176847714753,"['CEBPA', 'CEBPB', 'PPARG', 'ZNF423']",0.9056355123805784,0,0,4
65,MAPK pathway in congenital thyroid cancer WP4928,0.11812637118007543,2.484164859002169,5.306176847714753,"['JUN', 'FOS', 'ELK1', 'MAPK3']",0.9056355123805784,0,0,4
66,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.11812637118007543,2.484164859002169,5.306176847714753,"['GSK3A', 'BAX', 'BCL2L14', 'BCL2L2']",0.9056355123805784,0,0,4
67,Tryptophan metabolism WP465,0.12287562040407636,1.9617692439567975,4.113011363049206,"['TDO2', 'ALDH1A1', 'CYP1B1', 'DHCR24', 'CYP2C18', 'ACMSD']",0.9279860287233229,0,0,6
68,Adipogenesis WP236,0.13116878324167114,1.409641361733115,2.863362721099759,"['GDF10', 'WWTR1', 'CEBPA', 'EGR2', 'CDKN1A', 'CEBPB', 'GADD45B', 'GADD45A', 'HMGA1', 'LPL', 'MIF', 'CYP26B1', 'DDIT3', 'NDN', 'SPOCK1', 'PPARG', 'MEF2D']",0.9682588496606073,0,0,17
69,G1 to S cell cycle control WP45,0.13359665310053087,1.5935660277336012,3.2077369754942704,"['CDKN2D', 'CREB3', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'TFDP2', 'CDKN2A', 'GADD45A', 'RPA3', 'MCM4']",0.9682588496606073,0,0,10
70,NRF2 pathway WP2884,0.13394885271984686,1.4213349968808484,2.857305832738794,"['EGR1', 'HSP90AA1', 'SRXN1', 'SLC6A16', 'GSTP1', 'SLC39A11', 'NRG1', 'TXN', 'SLC7A11', 'SLC2A9', 'FTH1', 'PRDX1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'FTL']",0.9682588496606073,0,0,16
71,Oxidation by Cytochrome P450 WP43,0.14201855660001345,1.8635179153094463,3.637209700805657,"['CYP39A1', 'CYP26B1', 'CYP3A43', 'CYP1B1', 'CYP3A5', 'CYP2C18']",0.9740018232167497,0,0,6
72,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.14403267508152082,1.4917647058823529,2.890614988564704,"['PSMD8', 'TUBB8', 'HSPA8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'HSPA5', 'PSMD2', 'UBE2L6', 'STUB1', 'TUBA4A']",0.9740018232167497,0,0,12
73,Kynurenine Pathway and links to Cellular Senescence WP5044,0.1442500096130883,2.2581344902386116,4.372216500080489,"['CDKN1A', 'TDO2', 'KMO', 'ACMSD']",0.9740018232167497,0,0,4
74,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.14458096630811126,4.138317081979054,8.003155995192367,"['PPARG', 'CYP2C18']",0.9740018232167497,0,0,2
75,Translation Factors WP107,0.1474344560821896,1.5535908596300327,2.974150169213509,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EIF5', 'EIF6', 'EIF1AX', 'EIF4H', 'EEF2', 'GSPT2', 'EIF1']",0.9740018232167497,0,0,10
76,Aryl Hydrocarbon Receptor Netpath WP2586,0.14798780376988513,1.6568115942028985,3.165546340701565,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'LPL', 'CYP1B1', 'AHRR', 'HRAS']",0.9740018232167497,0,0,8
77,Glucocorticoid Receptor Pathway WP2880,0.14821766875037495,1.5978093684455839,3.050335285100816,"['HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'PLK2', 'ENC1', 'AMIGO2', 'BHLHE40', 'SPRY1']",0.9740018232167497,0,0,9
78,Dopaminergic Neurogenesis WP2855,0.15163021013463826,2.6608594657375146,5.019207283171715,"['NEUROD1', 'ALDH1A1', 'SLC18A2']",0.9836523888221406,0,0,3
79,Nuclear Receptors Meta-Pathway WP2882,0.1543218764088929,1.2447136563876653,2.326014770775374,"['CDKN1B', 'SRXN1', 'GSTP1', 'AMIGO2', 'TXN', 'SLC7A11', 'CYP3A5', 'FTH1', 'PRDX1', 'ENC1', 'CYP1B1', 'SLC39A7', 'SLC39A1', 'SLC39A3', 'EGR1', 'JUN', 'HSP90AA1', 'GADD45B', 'SLC6A16', 'SLC10A1', 'PLK2', 'SLC39A11', 'AIP', 'NRG1', 'SLC2A9', 'PSMC5', 'BHLHE40', 'AHRR', 'BAX', 'SPRY1', 'FKBP5', 'FTL']",0.9884413856063267,0,0,32
80,Metapathway biotransformation Phase I and II WP702,0.16582618158880555,1.3625650535383143,2.448277514815354,"['CHST8', 'CHST9', 'GAL3ST1', 'GPX4', 'GSTP1', 'CYP3A43', 'GLYAT', 'CYP2C18', 'CYP3A5', 'CYP39A1', 'CYP26B1', 'CYP1B1', 'NAT8L', 'SULT4A1', 'CHST2', 'SULT1A2']",0.9999514751263369,0,0,16
81,Methionine De Novo and Salvage Pathway WP3580,0.1723754182093807,2.0697758496023138,3.638832595145447,"['AHCY', 'ODC1', 'TXN', 'MAT2B']",0.9999514751263369,0,0,4
82,DNA Mismatch Repair WP531,0.18095392955092632,1.826465800644729,3.1223666886776185,"['POLE4', 'POLD4', 'RPA3', 'POLD2', 'POLE3']",0.9999514751263369,0,0,5
83,Prader-Willi and Angelman Syndrome WP3998,0.18270100814580245,1.5529891304347827,2.639932896911762,"['OCA2', 'MAGEL2', 'CDKN2C', 'CDKN2A', 'BDNF', 'NDN', 'GABRG3', 'GABRD']",0.9999514751263369,0,0,8
84,Hypertrophy Model WP516,0.18806119148332337,2.328048780487805,3.890141302059466,"['NR4A3', 'WDR1', 'IL18']",0.9999514751263369,0,0,3
85,ACE Inhibitor Pathway WP554,0.19759290537744778,3.1034669555796315,5.032415663980097,"['MAS1', 'ATP6AP2']",0.9999514751263369,0,0,2
86,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.19759290537744778,3.1034669555796315,5.032415663980097,"['CEBPB', 'ALDH1A1']",0.9999514751263369,0,0,2
87,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.19759290537744778,3.1034669555796315,5.032415663980097,"['AHCY', 'MAT2B']",0.9999514751263369,0,0,2
88,Peroxiredoxin 2 induced ovarian failure WP4873,0.19759290537744778,3.1034669555796315,5.032415663980097,"['STAR', 'BAX']",0.9999514751263369,0,0,2
89,Tamoxifen metabolism WP691,0.19759290537744778,3.1034669555796315,5.032415663980097,"['CYP1B1', 'CYP3A5']",0.9999514751263369,0,0,2
90,Cytosolic DNA-sensing pathway WP4655,0.20126219224830214,1.5057971014492753,2.4140137774102444,"['IL18', 'POLR2E', 'ISG15', 'POLR3H', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999514751263369,0,0,8
91,IL-3 signaling pathway WP286,0.2045416760000063,1.5526887561108094,2.4640914826074423,"['JUN', 'YWHAB', 'BAD', 'PIK3CD', 'FOS', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,7
92,16p11.2 distal deletion syndrome WP4950,0.20656472079685717,1.7248447579429673,2.720324244986577,"['PLN', 'CD81', 'NFATC2', 'TUFM', 'VAV2']",0.9999514751263369,0,0,5
93,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.20656472079685717,1.7248447579429673,2.720324244986577,"['EGR2', 'RAB3A', 'NEFL', 'RABAC1', 'NDRG1']",0.9999514751263369,0,0,5
94,Pre-implantation embryo WP3527,0.20656472079685717,1.7248447579429673,2.720324244986577,"['EGR1', 'ARGFX', 'DDIT3', 'HMGA1', 'ATP1A1']",0.9999514751263369,0,0,5
95,Oncostatin M Signaling Pathway WP2374,0.20944477205131684,1.411860718171926,2.2071550728684177,"['EGR1', 'CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'RPS6', 'TIMP3', 'FOS', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,10
96,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.21505318187036113,1.4334295394654286,2.2029947472424767,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'PRKCQ', 'ISG15', 'HRAS', 'PLCB2', 'MAPK3']",0.9999514751263369,0,0,9
97,Eukaryotic Transcription Initiation WP405,0.22054102339766687,1.461381074168798,2.2091281997328434,"['TAF13', 'POLR2E', 'TAF7', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999514751263369,0,0,8
98,Circadian rhythm related genes WP3594,0.22540681762053977,1.2129867351305093,1.807166384243126,"['CHRNB2', 'KLF10', 'EGR1', 'JUN', 'MAGEL2', 'EGR3', 'AHCY', 'KCNH7', 'SUV39H1', 'CIPC', 'BHLHE41', 'OPRL1', 'CARTPT', 'HCRTR2', 'PER2', 'CLDN4', 'DBP', 'STAR', 'UBC', 'BHLHE40', 'PPARG', 'RPS27A', 'UBA52', 'SKP1']",0.9999514751263369,0,0,24
99,Airway smooth muscle cell contraction WP4962,0.22641065607998567,2.069196025293586,3.0735938452369025,"['RYR1', 'CALM1', 'CALM2']",0.9999514751263369,0,0,3
100,Cancer immunotherapy by PD-1 blockade WP4585,0.22641065607998567,2.069196025293586,3.0735938452369025,"['JUN', 'NFATC2', 'PDCD1LG2']",0.9999514751263369,0,0,3
101,miRNAs involved in DNA damage response WP1545,0.22641065607998567,2.069196025293586,3.0735938452369025,"['CDKN1A', 'CDKN1B', 'H2AFX']",0.9999514751263369,0,0,3
102,Overview of nanoparticle effects WP3287,0.22641065607998567,2.069196025293586,3.0735938452369025,"['LAMA3', 'PIK3CD', 'BAX']",0.9999514751263369,0,0,3
103,Proteasome Degradation WP183,0.22642932771005986,1.3803651311812357,2.050287251851406,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMD2', 'H2AFX', 'UBC', 'PSME1', 'PSMB10']",0.9999514751263369,0,0,10
104,Heart Development WP1591,0.23337082630886238,1.7737837000309886,2.5810797759769657,"['HEY1', 'BHLHE40', 'NFATC2', 'FGF10']",0.9999514751263369,0,0,4
105,Ovarian infertility WP34,0.23337082630886238,1.7737837000309886,2.5810797759769657,"['EGR1', 'CEBPB', 'CDKN1B', 'FSHR']",0.9999514751263369,0,0,4
106,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.23337082630886238,1.7737837000309886,2.5810797759769657,"['JUN', 'SRXN1', 'GSTP1', 'FOS']",0.9999514751263369,0,0,4
107,"Relationship between inflammation, COX-2 and EGFR WP4483",0.23337082630886238,1.7737837000309886,2.5810797759769657,"['PTGES2', 'PIK3CD', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,4
108,TYROBP causal network in microglia WP3945,0.23337082630886238,1.7737837000309886,2.5810797759769657,"['RBM47', 'IL18', 'LHFPL2', 'SAMSN1']",0.9999514751263369,0,0,4
109,Hepatitis B infection WP4666,0.2409941576968419,1.2299184435939494,1.7501525295340563,"['JUN', 'EGR2', 'CDKN1A', 'TICAM2', 'EGR3', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'BAD', 'NFATC2', 'PIK3CD', 'FOS', 'ELK1', 'CREB3', 'CYCS', 'BAX', 'FADD', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,19
110,22q11.2 copy number variation syndrome WP4657,0.2425202038432037,1.2790749887741355,1.8120274933986096,"['RANBP1', 'SERPIND1', 'EMC10', 'RTN4', 'SLC7A4', 'ACTA2', 'CYP26B1', 'MRPL40', 'THAP7', 'CLTCL1', 'DGCR6L', 'HIST1H4C', 'RAN', 'FGF10']",0.9999514751263369,0,0,14
111,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.252247193448952,1.3632674173397525,1.8776905777695587,"['CDKN1A', 'JUN', 'CDKN1B', 'TMSB4X', 'NEFL', 'NEFM', 'ELK1', 'PFN2', 'SOD1']",0.9999514751263369,0,0,9
112,Bile acids synthesis and enterohepatic circulation  WP4389,0.25238041833455416,2.4825568797399784,3.4180283357048644,"['SLC10A1', 'MAPK3']",0.9999514751263369,0,0,2
113,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.25238041833455416,2.4825568797399784,3.4180283357048644,"['CLDN4', 'NRG3']",0.9999514751263369,0,0,2
114,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.25238041833455416,2.4825568797399784,3.4180283357048644,"['LPL', 'LDLRAP1']",0.9999514751263369,0,0,2
115,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.25238041833455416,2.4825568797399784,3.4180283357048644,"['ELK1', 'MEF2D']",0.9999514751263369,0,0,2
116,Sulfation Biotransformation Reaction WP692,0.25238041833455416,2.4825568797399784,3.4180283357048644,"['SULT4A1', 'SULT1A2']",0.9999514751263369,0,0,2
117,IL-5 signaling pathway WP127,0.2545293090790939,1.4901628664495115,2.039048393068917,"['GSK3A', 'JUN', 'RPS6', 'FOS', 'ELK1', 'MAPK3']",0.9999514751263369,0,0,6
118,Oxidative Damage WP3941,0.2545293090790939,1.4901628664495115,2.039048393068917,"['CDKN1A', 'CDKN1B', 'BAD', 'GADD45A', 'CYCS', 'NFKBIE']",0.9999514751263369,0,0,6
119,Arylamine metabolism WP694,0.2584171857597866,6.205197617758527,8.396749318150489,['SULT1A2'],0.9999514751263369,0,0,1
120,Gastric acid production WP2596,0.2584171857597866,6.205197617758527,8.396749318150489,['CCK'],0.9999514751263369,0,0,1
121,Nanomaterial-induced inflammasome activation WP3890,0.2584171857597866,6.205197617758527,8.396749318150489,['CTSB'],0.9999514751263369,0,0,1
122,SCFA and skeletal muscle substrate metabolism WP4030,0.2584171857597866,6.205197617758527,8.396749318150489,['PYY'],0.9999514751263369,0,0,1
123,Thyroxine (Thyroid Hormone) Production WP1981,0.2584171857597866,6.205197617758527,8.396749318150489,['TSHR'],0.9999514751263369,0,0,1
124,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.26015502366659227,1.1971949804914057,1.6119962010521705,"['SHC4', 'VAV3', 'EGR1', 'JUN', 'EGR2', 'RAB3A', 'BDNF', 'BAD', 'RPS6', 'PRKCD', 'FOS', 'EEF2', 'ELK1', 'ACACB', 'VAV2', 'GRIP1', 'MARCKS', 'CFL1', 'HRAS', 'MAPK3', 'CDK5R1']",0.9999514751263369,0,0,21
125,Synaptic Vesicle Pathway WP2267,0.2609672508495459,1.3799516908212561,1.8537723935465718,"['RAB3A', 'CLTCL1', 'AP2S1', 'PARK7', 'SYN3', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.9999514751263369,0,0,8
126,Canonical and non-canonical Notch signaling WP3845,0.26559719836329715,1.6553868402024585,2.1946695110045664,"['JAG1', 'HEY1', 'CNTN6', 'DLL3']",0.9999514751263369,0,0,4
127,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.26559719836329715,1.6553868402024585,2.1946695110045664,"['LDHA', 'RPS6', 'PDHB', 'ACACB']",0.9999514751263369,0,0,4
128,Striated Muscle Contraction Pathway WP383,0.26559719836329715,1.6553868402024585,2.1946695110045664,"['ACTA2', 'MYOM1', 'TCAP', 'ACTG1']",0.9999514751263369,0,0,4
129,BMP Signaling Pathway in Eyelid Development WP3927,0.2660451693344715,1.8621138211382113,2.46560475335152,"['JUN', 'MAPK3', 'FGF10']",0.9999514751263369,0,0,3
130,Tryptophan catabolism leading to NAD+ production WP4210,0.2660451693344715,1.8621138211382113,2.46560475335152,"['NMNAT1', 'TDO2', 'KMO']",0.9999514751263369,0,0,3
131,Type II diabetes mellitus WP1584,0.2660451693344715,1.8621138211382113,2.46560475335152,"['SURF1', 'KCNJ11', 'PRKCD']",0.9999514751263369,0,0,3
132,PDGF Pathway WP2526,0.2700754994839433,1.4020605911934256,1.8353726484861455,"['JUN', 'ARFIP2', 'FOS', 'ELK1', 'HRAS', 'MAPK3', 'VAV2']",0.9999514751263369,0,0,7
133,G13 Signaling Pathway WP524,0.2795241301531253,1.4327236281633675,1.8262450372703445,"['CFL2', 'CFL1', 'ARHGDIG', 'PIK3CD', 'CALM1', 'CALM2']",0.9999514751263369,0,0,6
134,Alpha 6 Beta 4 signaling pathway WP244,0.2891615641108078,1.4780507970958323,1.8339206466266464,"['LAMA2', 'LAMA3', 'PRKCD', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,5
135,Small cell lung cancer WP4658,0.29853295437435784,1.2232515894641236,1.4787582068998228,"['CDKN1A', 'CDKN1B', 'LAMA2', 'GADD45B', 'GADD45A', 'LAMA4', 'LAMA3', 'PIK3CD', 'FHIT', 'CKS1B', 'CYCS', 'BAX', 'SKP1']",0.9999514751263369,0,0,13
136,Complement and Coagulation Cascades WP558,0.29855658261361523,1.5517895878524945,1.8757967481021653,"['SERPIND1', 'F12', 'CLU', 'KLKB1']",0.9999514751263369,0,0,4
137,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.29855658261361523,1.5517895878524945,1.8757967481021653,"['BDNF', 'FSHR', 'RPS6', 'MAPK3']",0.9999514751263369,0,0,4
138,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.29855658261361523,1.5517895878524945,1.8757967481021653,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999514751263369,0,0,4
139,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.29855658261361523,1.5517895878524945,1.8757967481021653,"['GSK3A', 'NFATC2', 'CALM1', 'CALM2']",0.9999514751263369,0,0,4
140,Parkinson's disease pathway WP2371,0.30503808326918336,1.37953914826879,1.6379525549947653,"['PINK1', 'CASP6', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.9999514751263369,0,0,6
141,Non-small cell lung cancer WP4255,0.3052137239692863,1.2419161676646706,1.4738353352652318,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PIK3CD', 'CYCS', 'BAX', 'HRAS', 'FHIT', 'MAPK3']",0.9999514751263369,0,0,11
142,Imatinib and Chronic Myeloid Leukemia WP3640,0.3063866558450476,1.6926829268292682,2.002287148969884,"['SPRED2', 'CDKN1B', 'GADD45A']",0.9999514751263369,0,0,3
143,Farnesoid X receptor pathway WP2879,0.30742945634547186,2.0686168291802094,2.439953467307851,"['SLC10A1', 'FKBP5']",0.9999514751263369,0,0,2
144,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.30742945634547186,2.0686168291802094,2.439953467307851,"['ELOB', 'ELOC']",0.9999514751263369,0,0,2
145,IL1 and megakaryocytes in obesity WP2865,0.30742945634547186,2.0686168291802094,2.439953467307851,"['IL18', 'TIMP2']",0.9999514751263369,0,0,2
146,Breast cancer pathway WP4262,0.3130038690186577,1.1731537107834213,1.3626646414643857,"['SHC4', 'JUN', 'CDKN1A', 'GADD45B', 'GADD45A', 'PIK3CD', 'FOS', 'FGF1', 'DLL3', 'FGF17', 'FRAT2', 'HEY1', 'BAX', 'HRAS', 'SKP1', 'FGF10', 'MAPK3']",0.9999514751263369,0,0,17
147,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.3164908338707937,1.3168567807351077,1.5149923671502614,"['JUN', 'NFATC2', 'PRKCQ', 'FOS', 'CALM1', 'CALM2', 'MAPK3']",0.9999514751263369,0,0,7
148,GABA receptor Signaling WP4159,0.3179635256065308,1.410743353228432,1.616455976961753,"['GABBR1', 'AP2S1', 'GABRD', 'GABRG3', 'AP2M1']",0.9999514751263369,0,0,5
149,DNA Replication WP466,0.33093630197644397,1.3301535597952536,1.4709228640970402,"['POLD4', 'RPA3', 'UBC', 'POLD2', 'MCM4', 'UBA52']",0.9999514751263369,0,0,6
150,NO/cGMP/PKG mediated Neuroprotection WP4008,0.33093630197644397,1.3301535597952536,1.4709228640970402,"['BAD', 'PDE3A', 'NEFL', 'CYCS', 'CALM1', 'CALM2']",0.9999514751263369,0,0,6
151,G Protein Signaling Pathways WP35,0.33146289985904576,1.1870652348132713,1.3108041926558869,"['PRKCH', 'PRKCD', 'AKAP5', 'GNG10', 'GNG3', 'PRKD3', 'PRKAR1A', 'PRKCQ', 'PRKD1', 'PDE7B', 'CALM1', 'HRAS', 'CALM2']",0.9999514751263369,0,0,13
152,Acute viral myocarditis WP4298,0.3318740245709826,1.2416530723219141,1.3695431228923862,"['ENDOG', 'LAMA2', 'CASP6', 'CYCS', 'BAX', 'ACTB', 'SGCG', 'EIF4G2', 'MAPK3']",0.9999514751263369,0,0,9
153,Type II interferon signaling (IFNG) WP619,0.3319521591225585,1.4603802475437029,1.6104553758987192,"['PRKCD', 'TAP1', 'ISG15', 'IFIT2']",0.9999514751263369,0,0,4
154,Apoptosis WP254,0.33725187290510494,1.2173291514647209,1.3231457684863213,"['JUN', 'CRADD', 'CASP6', 'CDKN2A', 'BAD', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2']",0.9999514751263369,0,0,10
155,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.33725187290510494,1.2173291514647209,1.3231457684863213,"['EGR1', 'JUN', 'CDKN1B', 'APEX1', 'RPS6', 'FOS', 'HRAS', 'TSHR', 'MYL12B', 'MAPK3']",0.9999514751263369,0,0,10
156,Pathogenic Escherichia coli infection WP2272,0.340214373550957,1.2780138671438157,1.3779281600775226,"['TUBB8', 'TUBA1A', 'TUBB2A', 'ARPC5L', 'ACTB', 'TUBA4A', 'ACTG1']",0.9999514751263369,0,0,7
157,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.340214373550957,1.2780138671438157,1.3779281600775226,"['CDKN1A', 'HSP90AA1', 'JUN', 'CDKN2A', 'BAX', 'FOS', 'ELK1']",0.9999514751263369,0,0,7
158,ERK Pathway in Huntington's Disease WP3853,0.3469208097747116,1.551490514905149,1.6424989920578588,"['BDNF', 'ELK1', 'HRAS']",0.9999514751263369,0,0,3
159,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.3469208097747116,1.551490514905149,1.6424989920578588,"['JUN', 'PRKCQ', 'MAPK3']",0.9999514751263369,0,0,3
160,PDGFR-beta pathway WP3972,0.3470832903007237,1.3492887305668924,1.427804513950419,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,5
161,Prion disease pathway WP3995,0.3470832903007237,1.3492887305668924,1.427804513950419,"['PRNP', 'HSPA5', 'ELK1', 'HSP90B1', 'MAPK3']",0.9999514751263369,0,0,5
162,Genotoxicity pathway WP4286,0.3471522853395581,1.2415217391304347,1.3135197359143151,"['ACTA2', 'PLK3', 'CDKN1A', 'RPS27', 'GADD45A', 'PCDH8', 'TRIAP1', 'TRIM22']",0.9999514751263369,0,0,8
163,Prolactin Signaling Pathway WP2037,0.35672786346846735,1.1938143466979159,1.2305624295666184,"['JUN', 'RPS6KA2', 'RPS6', 'FOS', 'ELK1', 'CTSD', 'HRAS', 'YWHAG', 'VAV2', 'MAPK3']",0.9999514751263369,0,0,10
164,Copper homeostasis WP3286,0.35708690882551153,1.2841738739750646,1.3224115440692987,"['PRNP', 'JUN', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9999514751263369,0,0,6
165,Fas ligand pathway and stress induction of heat shock proteins WP314,0.35708690882551153,1.2841738739750646,1.3224115440692987,"['JUN', 'CASP6', 'CYCS', 'FADD', 'ACTB', 'ACTG1']",0.9999514751263369,0,0,6
166,let-7 inhibition of ES cell reprogramming WP3299,0.36139608673857176,3.102328099621007,3.157489754656153,['EGR1'],0.9999514751263369,0,0,1
167,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.36139608673857176,3.102328099621007,3.157489754656153,['NRP1'],0.9999514751263369,0,0,1
168,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.36139608673857176,3.102328099621007,3.157489754656153,['MAS1'],0.9999514751263369,0,0,1
169,Estrogen Receptor Pathway WP2881,0.3616117963580305,1.7729453644946602,1.8034117078562446,"['JUN', 'CYP1B1']",0.9999514751263369,0,0,2
170,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.3616117963580305,1.7729453644946602,1.8034117078562446,"['PRKCQ', 'MAFK']",0.9999514751263369,0,0,2
171,Genes targeted by miRNAs in adipocytes WP1992,0.3616117963580305,1.7729453644946602,1.8034117078562446,"['TMSB4X', 'KCNJ2']",0.9999514751263369,0,0,2
172,Matrix Metalloproteinases WP129,0.3616117963580305,1.7729453644946602,1.8034117078562446,"['TIMP2', 'TIMP3']",0.9999514751263369,0,0,2
173,Neuroinflammation WP4919,0.3616117963580305,1.7729453644946602,1.8034117078562446,"['JUN', 'FOS']",0.9999514751263369,0,0,2
174,Purine metabolism WP4792,0.3616117963580305,1.7729453644946602,1.8034117078562446,"['PRPS1', 'APRT']",0.9999514751263369,0,0,2
175,Osteoblast differentiation WP4787,0.36512712526316843,1.1529466718567536,1.161604952764044,"['PRKCH', 'JAG1', 'PRKCD', 'PIK3CD', 'WNT9A', 'FGF1', 'DLL3', 'HEY1', 'PRKCQ', 'PPARG', 'PRKD1', 'FGF10', 'MAPK3']",0.9999514751263369,0,0,13
176,7-oxo-C and 7beta-HC pathways WP5064,0.3655073136078094,1.3791275006025547,1.3880490627803947,"['HSD11B1', 'HSD11B2', 'DBP', 'ACOT11']",0.9999514751263369,0,0,4
177,Physiological and pathological hypertrophy of the heart WP1528,0.3655073136078094,1.3791275006025547,1.3880490627803947,"['JUN', 'FOS', 'CALM1', 'CALM2']",0.9999514751263369,0,0,4
178,Glycogen Synthesis and Degradation WP500,0.38336260571183484,1.2412595005428881,1.1900873195940493,"['GYS2', 'GSK3A', 'PHKA1', 'CALM3', 'CALM1', 'CALM2']",0.9999514751263369,0,0,6
179,Microglia Pathogen Phagocytosis Pathway WP3937,0.3872005046765846,1.4320200125078173,1.35871866021816,"['VAV3', 'PIK3CD', 'VAV2']",0.9999514751263369,0,0,3
180,One-carbon metabolism WP241,0.3872005046765846,1.4320200125078173,1.35871866021816,"['AHCY', 'DNMT3A', 'MAT2B']",0.9999514751263369,0,0,3
181,Pregnane X receptor pathway WP2876,0.3872005046765846,1.4320200125078173,1.35871866021816,"['HSP90AA1', 'PSMC5', 'CYP3A5']",0.9999514751263369,0,0,3
182,Transcription factor regulation in adipogenesis WP3599,0.3872005046765846,1.4320200125078173,1.35871866021816,"['CEBPA', 'CEBPB', 'PPARG']",0.9999514751263369,0,0,3
183,Modulators of TCR signaling and T cell activation WP5072,0.38819825382388123,1.2068018588931138,1.1419231125519869,"['FIBP', 'CDKN1B', 'NDUFB10', 'ELOB', 'PRKCQ', 'RNF7', 'MEF2D']",0.9999514751263369,0,0,7
184,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3960665963679922,1.1493974932495064,1.064540820173813,"['CDKN1A', 'JUN', 'GADD45B', 'DCC', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'FOS', 'MAPK3']",0.9999514751263369,0,0,10
185,TNF-alpha signaling pathway WP231,0.39849880677320526,1.1285403050108933,1.0383143823026315,"['HSP90AA1', 'JUN', 'BAD', 'PSMD2', 'RFK', 'BAX', 'TXN', 'FADD', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3']",0.9999514751263369,0,0,12
186,Hematopoietic Stem Cell Differentiation WP2849,0.3989689024387799,1.306427674392054,1.2004395538068322,"['NFATC2', 'FOS', 'ABO', 'RUNX1']",0.9999514751263369,0,0,4
187,Neural Crest Cell Migration during Development WP4564,0.4055727955108361,1.2411285946825827,1.1200625832492463,"['JUN', 'BDNF', 'PIK3CD', 'FOS', 'EPHB3']",0.9999514751263369,0,0,5
188,Common Pathways Underlying Drug Addiction WP2636,0.40964200648398186,1.2011137963644005,1.0719600184326015,"['PPP1R1A', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9999514751263369,0,0,6
189,IL-4 signaling pathway WP395,0.41226897706647986,1.1740828280752236,1.0403304736459338,"['CEBPA', 'CEBPB', 'BAD', 'PIK3CD', 'FOS', 'ELK1', 'MAPK3']",0.9999514751263369,0,0,7
190,Cysteine and methionine catabolism WP4504,0.4141071758828524,1.5511917659804983,1.367577909749226,"['AHCY', 'GOT1']",0.9999514751263369,0,0,2
191,Development and heterogeneity of the ILC family WP3893,0.4141071758828524,1.5511917659804983,1.367577909749226,"['IL18', 'TOX']",0.9999514751263369,0,0,2
192,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4141071758828524,1.5511917659804983,1.367577909749226,"['GABBR1', 'GRM4']",0.9999514751263369,0,0,2
193,Nanoparticle triggered regulated necrosis WP2513,0.4141071758828524,1.5511917659804983,1.367577909749226,"['FADD', 'FTL']",0.9999514751263369,0,0,2
194,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.42684564864881436,1.3296167247386759,1.1319463420651028,"['EIF5', 'EIF1AX', 'EIF1']",0.9999514751263369,0,0,3
195,Triacylglyceride synthesis WP325,0.42684564864881436,1.3296167247386759,1.1319463420651028,"['DGAT2', 'LPL', 'AGPAT1']",0.9999514751263369,0,0,3
196,Cell migration and invasion through p75NTR WP4561,0.4321092730962454,1.240997830802603,1.0412924585722565,"['JUN', 'EFNA3', 'EFNB3', 'BDNF']",0.9999514751263369,0,0,4
197,IL-2 signaling pathway WP49,0.4346196098203597,1.1932885345799074,0.9943483514084138,"['JUN', 'RPS6', 'FOS', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,5
198,Leptin signaling pathway WP2034,0.4355779591038784,1.108153272190269,0.9209656705375285,"['GSK3A', 'BAD', 'CFL2', 'RPS6', 'LEPR', 'BAX', 'ELK1', 'HRAS', 'ACACB', 'MAPK3']",0.9999514751263369,0,0,10
199,TGF-beta Receptor Signaling WP560,0.43581071768101864,1.1634771986970684,0.966322803703507,"['JUN', 'FOS', 'ZNF423', 'HRAS', 'LTBP1', 'MAPK3']",0.9999514751263369,0,0,6
200,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.43627246953129023,1.1430858515109066,0.948176340527396,"['VAV3', 'BEX3', 'CDKN1A', 'CDKN1B', 'HSPA5', 'NRG1', 'RNF7']",0.9999514751263369,0,0,7
201,Cell cycle WP179,0.4492808449265157,1.0725662048817266,0.8581678324885802,"['CDKN2D', 'CDKN1A', 'CDKN1B', 'CDKN2C', 'GADD45B', 'GADD45A', 'YWHAB', 'CDKN2A', 'ANAPC11', 'TFDP2', 'MCM4', 'YWHAG', 'SKP1', 'YWHAH']",0.9999514751263369,0,0,14
202,Cells and molecules involved in local acute inflammatory response  WP4493,0.4500816049026579,2.0680382602418335,1.6509694740742333,['SELP'],0.9999514751263369,0,0,1
203,Composition of Lipid Particles WP3601,0.4500816049026579,2.0680382602418335,1.6509694740742333,['LPL'],0.9999514751263369,0,0,1
204,Fatty Acid Omega Oxidation WP206,0.4500816049026579,2.0680382602418335,1.6509694740742333,['ALDH1A1'],0.9999514751263369,0,0,1
205,Irinotecan pathway WP229,0.4500816049026579,2.0680382602418335,1.6509694740742333,['CYP3A5'],0.9999514751263369,0,0,1
206,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4500816049026579,2.0680382602418335,1.6509694740742333,['SELP'],0.9999514751263369,0,0,1
207,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.4500816049026579,2.0680382602418335,1.6509694740742333,['ATP4A'],0.9999514751263369,0,0,1
208,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4500816049026579,2.0680382602418335,1.6509694740742333,['DLL3'],0.9999514751263369,0,0,1
209,Sulindac Metabolic Pathway WP2542,0.4500816049026579,2.0680382602418335,1.6509694740742333,['CYP1B1'],0.9999514751263369,0,0,1
210,Vitamin B6-dependent and responsive disorders WP4228,0.4500816049026579,2.0680382602418335,1.6509694740742333,['AASS'],0.9999514751263369,0,0,1
211,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4552748503191469,1.0886165358990512,0.8565822493616868,"['CREB3', 'BAD', 'RPS6', 'DIO1', 'ZNF516', 'ITPR2', 'PRKCQ', 'PPARG', 'HRAS', 'TSHR']",0.9999514751263369,0,0,10
212,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4633409836459165,1.1489921826329856,0.8839105288568504,"['JUN', 'FOS', 'ELK1', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,5
213,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.46433959535754593,1.378716744913928,1.0576675337508115,"['RPH3AL', 'EXPH5']",0.9999514751263369,0,0,2
214,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.46433959535754593,1.378716744913928,1.0576675337508115,"['CDKN1A', 'ROS1']",0.9999514751263369,0,0,2
215,GDNF/RET signaling axis WP4830,0.46433959535754593,1.378716744913928,1.0576675337508115,"['GFRA1', 'SPRY1']",0.9999514751263369,0,0,2
216,GPR40 Pathway WP3958,0.46433959535754593,1.378716744913928,1.0576675337508115,"['PLCH1', 'PLCB2']",0.9999514751263369,0,0,2
217,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.46433959535754593,1.378716744913928,1.0576675337508115,"['JAG1', 'SOX4']",0.9999514751263369,0,0,2
218,Homologous recombination WP186,0.46433959535754593,1.378716744913928,1.0576675337508115,"['POLD4', 'POLD2']",0.9999514751263369,0,0,2
219,"NAD metabolism, sirtuins and aging WP3630",0.46433959535754593,1.378716744913928,1.0576675337508115,"['PPARG', 'ROS1']",0.9999514751263369,0,0,2
220,RalA downstream regulated genes WP2290,0.46433959535754593,1.378716744913928,1.0576675337508115,"['EXOC8', 'HRAS']",0.9999514751263369,0,0,2
221,RAS and bradykinin pathways in COVID-19 WP4969,0.46433959535754593,1.378716744913928,1.0576675337508115,"['F12', 'KLKB1']",0.9999514751263369,0,0,2
222,Apoptosis Modulation by HSP70 WP384,0.46554059685110455,1.2408672086720867,0.9487124383076718,"['CASP6', 'CYCS', 'FADD']",0.9999514751263369,0,0,3
223,Globo Sphingolipid Metabolism WP1424,0.46554059685110455,1.2408672086720867,0.9487124383076718,"['ST6GALNAC3', 'FUT1', 'ABO']",0.9999514751263369,0,0,3
224,NAD+ biosynthetic pathways WP3645,0.46554059685110455,1.2408672086720867,0.9487124383076718,"['NMNAT1', 'TDO2', 'ACMSD']",0.9999514751263369,0,0,3
225,Nucleotide metabolism WP404,0.46554059685110455,1.2408672086720867,0.9487124383076718,"['PRPS1', 'NME2', 'OAZ1']",0.9999514751263369,0,0,3
226,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.46554059685110455,1.2408672086720867,0.9487124383076718,"['ELK1', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,3
227,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.46554059685110455,1.2408672086720867,0.9487124383076718,"['EGR1', 'ELK1', 'MAPK3']",0.9999514751263369,0,0,3
228,Glioblastoma signaling pathways WP2261,0.4909006351948866,1.0499309074159373,0.7470400608691214,"['CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CDKN2A', 'PRKCD', 'PIK3CD', 'SPRY2', 'PRKCQ', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,11
229,Amyotrophic lateral sclerosis (ALS) WP2447,0.4916093461888877,1.1078598558251298,0.7866590334835378,"['BAD', 'NEFL', 'BAX', 'NEFM', 'SOD1']",0.9999514751263369,0,0,5
230,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4916093461888877,1.1078598558251298,0.7866590334835378,"['JUN', 'RPS6KA2', 'DDIT3', 'FOS', 'MAPK3']",0.9999514751263369,0,0,5
231,Neural Crest Cell Migration in Cancer WP4565,0.4916093461888877,1.1078598558251298,0.7866590334835378,"['JUN', 'BDNF', 'PIK3CD', 'FOS', 'EPHB3']",0.9999514751263369,0,0,5
232,Type 2 papillary renal cell carcinoma WP4241,0.4916093461888877,1.1078598558251298,0.7866590334835378,"['CDKN1A', 'EGLN2', 'COL21A1', 'ELOB', 'ELOC']",0.9999514751263369,0,0,5
233,Development of ureteric collection system WP5053,0.49664826684495894,1.1279826464208242,0.7894448423628936,"['GRIP1', 'FRAS1', 'GFRA1', 'SPRY1']",0.9999514751263369,0,0,4
234,Folate Metabolism WP176,0.49664826684495894,1.1279826464208242,0.7894448423628936,"['AHCY', 'GPX4', 'RFK', 'SOD1']",0.9999514751263369,0,0,4
235,Gastric Cancer Network 1 WP2361,0.5030299655866474,1.1632113821138212,0.7992489812656736,"['MCM4', 'GATD3B', 'GATD3A']",0.9999514751263369,0,0,3
236,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5030299655866474,1.1632113821138212,0.7992489812656736,"['BAD', 'BAX', 'FADD']",0.9999514751263369,0,0,3
237,IL-7 signaling pathway WP205,0.5030299655866474,1.1632113821138212,0.7992489812656736,"['CDKN1B', 'BAD', 'MAPK3']",0.9999514751263369,0,0,3
238,Trans-sulfuration and one-carbon metabolism WP2525,0.5030299655866474,1.1632113821138212,0.7992489812656736,"['AHCY', 'DNMT3A', 'MAT2B']",0.9999514751263369,0,0,3
239,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5119253581357966,1.2407367280606718,0.8307680930910971,"['RYR1', 'CCK']",0.9999514751263369,0,0,2
240,Ganglio Sphingolipid Metabolism WP1423,0.5119253581357966,1.2407367280606718,0.8307680930910971,"['B3GALT1', 'FUT1']",0.9999514751263369,0,0,2
241,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5119253581357966,1.2407367280606718,0.8307680930910971,"['ADCY10', 'ADRA1D']",0.9999514751263369,0,0,2
242,NOTCH1 regulation of endothelial cell calcification WP3413,0.5119253581357966,1.2407367280606718,0.8307680930910971,"['JAG1', 'DLL3']",0.9999514751263369,0,0,2
243,ATM Signaling Pathway WP2516,0.5193115814779956,1.0695642412109192,0.7008332806445026,"['CDKN1A', 'JUN', 'CRADD', 'GADD45A', 'H2AFX']",0.9999514751263369,0,0,5
244,Phosphoinositides metabolism WP4971,0.5193115814779956,1.0695642412109192,0.7008332806445026,"['PIP4P1', 'PIK3CD', 'PLCH1', 'PIP4K2C', 'PLCB2']",0.9999514751263369,0,0,5
245,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.526456719623222,1.550893340552247,0.9950316947636593,['CDKN1A'],0.9999514751263369,0,0,1
246,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.526456719623222,1.550893340552247,0.9950316947636593,['HEY1'],0.9999514751263369,0,0,1
247,PTF1A related regulatory pathway WP4147,0.526456719623222,1.550893340552247,0.9950316947636593,['FGF10'],0.9999514751263369,0,0,1
248,SARS-CoV-2 and COVID-19 Pathway WP4846,0.526456719623222,1.550893340552247,0.9950316947636593,['NRP1'],0.9999514751263369,0,0,1
249,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.526456719623222,1.550893340552247,0.9950316947636593,['MAPK3'],0.9999514751263369,0,0,1
250,The alternative pathway of fetal androgen synthesis WP4524,0.526456719623222,1.550893340552247,0.9950316947636593,['STAR'],0.9999514751263369,0,0,1
251,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5277238577096559,1.0788456097330945,0.68957883352795,"['NDUFA13', 'HSP90AA1', 'IL18', 'AAMP']",0.9999514751263369,0,0,4
252,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5373765884828873,1.0338400289540355,0.6420727062016242,"['JUN', 'FOS', 'ZNF423', 'HRAS', 'LTBP1', 'MAPK3']",0.9999514751263369,0,0,6
253,T-cell receptor (TCR) signaling pathway WP69,0.5383888495810478,1.0150081566068516,0.6284668746818024,"['VAV3', 'JUN', 'PRKCD', 'NFATC2', 'PRKCQ', 'FOS', 'HRAS', 'SKAP1', 'MAPK3']",0.9999514751263369,0,0,9
254,Pancreatic adenocarcinoma pathway WP4263,0.5454304098548217,1.0033462486791123,0.6082084823509606,"['CDKN1A', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PRKCD', 'PIK3CD', 'BAX', 'DUSP6', 'ARHGEF6', 'MAPK3']",0.9999514751263369,0,0,11
255,Biomarkers for pyrimidine metabolism disorders WP4584,0.5566308190687898,1.1278439869989165,0.6607508523341715,"['NT5C', 'CKB']",0.9999514751263369,0,0,2
256,Fatty acid transporters WP5061,0.5566308190687898,1.1278439869989165,0.6607508523341715,"['FABP7', 'ACSL5']",0.9999514751263369,0,0,2
257,"GPCRs, Class B Secretin-like WP334",0.5566308190687898,1.1278439869989165,0.6607508523341715,"['ADGRG2', 'PTH1R']",0.9999514751263369,0,0,2
258,Nicotine Activity on Dopaminergic Neurons WP1602,0.5566308190687898,1.1278439869989165,0.6607508523341715,"['CHRNB2', 'SLC18A2']",0.9999514751263369,0,0,2
259,Phytochemical activity on NRF2 transcriptional activation WP3,0.5566308190687898,1.1278439869989165,0.6607508523341715,"['CEBPB', 'SLC7A11']",0.9999514751263369,0,0,2
260,B Cell Receptor Signaling Pathway WP23,0.5698664843978596,0.9844206090125568,0.5535920633713902,"['JUN', 'GSK3A', 'CD81', 'PRKCD', 'NFATC2', 'ELK1', 'ILF2', 'HRAS', 'MEF2D', 'VAV2']",0.9999514751263369,0,0,10
261,Cardiac Progenitor Differentiation WP2406,0.5736403485065855,1.0337850045167118,0.5745287553623831,"['MESP1', 'NRG1', 'THY1']",0.9999514751263369,0,0,3
262,Nucleotide Excision Repair WP4753,0.5851411176939725,0.9792559574832848,0.5247854552863116,"['POLE4', 'POLD4', 'CETN2', 'RPA3', 'POLD2', 'POLE3']",0.9999514751263369,0,0,6
263,Phosphodiesterases in neuronal function WP4222,0.5851411176939725,0.9792559574832848,0.5247854552863116,"['ADCY10', 'PDE10A', 'PDE3A', 'PDE6C', 'PDE5A', 'PDE7B']",0.9999514751263369,0,0,6
264,Melatonin metabolism and effects WP3298,0.586868714677631,0.9923644251626899,0.5288847276790737,"['PER2', 'CYP1B1', 'CALM1', 'CALM2']",0.9999514751263369,0,0,4
265,Vitamin A and carotenoid metabolism WP716,0.586868714677631,0.9923644251626899,0.5288847276790737,"['CYP26B1', 'RBP4', 'ALDH1A1', 'LPL']",0.9999514751263369,0,0,4
266,EGF/EGFR signaling pathway WP437,0.5885538985348904,0.9687841903719913,0.5135396824758258,"['VAV3', 'NDUFA13', 'JUN', 'CAV2', 'LIMK2', 'PRKCD', 'NEDD8', 'FOS', 'ELK1', 'EPN1', 'VAV2', 'RPS6KA2', 'CFL1', 'STMN1', 'AP2S1', 'SPRY2', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.9999514751263369,0,0,20
267,Benzo(a)pyrene metabolism WP696,0.5922294340167606,1.2406063887384948,0.649905504039794,['CYP1B1'],0.9999514751263369,0,0,1
268,Drug Induction of Bile Acid Pathway WP2289,0.5922294340167606,1.2406063887384948,0.649905504039794,['SLC10A1'],0.9999514751263369,0,0,1
269,EDA signaling in hair follicle development WP3930,0.5922294340167606,1.2406063887384948,0.649905504039794,['SOSTDC1'],0.9999514751263369,0,0,1
270,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5922294340167606,1.2406063887384948,0.649905504039794,['RPS6'],0.9999514751263369,0,0,1
271,Insulin signaling in adipocytes (normal condition) WP3634,0.5922294340167606,1.2406063887384948,0.649905504039794,['RPS6'],0.9999514751263369,0,0,1
272,LDLRAD4 and what we know about it WP4904,0.5922294340167606,1.2406063887384948,0.649905504039794,['PMEPA1'],0.9999514751263369,0,0,1
273,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5922294340167606,1.2406063887384948,0.649905504039794,['BAX'],0.9999514751263369,0,0,1
274,miRNA Biogenesis WP2338,0.5922294340167606,1.2406063887384948,0.649905504039794,['RAN'],0.9999514751263369,0,0,1
275,Nephrogenesis WP5052,0.5922294340167606,1.2406063887384948,0.649905504039794,['JAG1'],0.9999514751263369,0,0,1
276,Vitamin B12 Disorders WP4271,0.5922294340167606,1.2406063887384948,0.649905504039794,['CUBN'],0.9999514751263369,0,0,1
277,ErbB signaling pathway WP673,0.5977042205005929,0.9606983216665261,0.49443228917698034,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'NRG3', 'BAD', 'PIK3CD', 'NRG1', 'ELK1', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,11
278,Eicosanoid Synthesis WP167,0.5983381493306478,1.0337667027807873,0.53094176987354,"['PTGES2', 'PTGES']",0.9999514751263369,0,0,2
279,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.5983381493306478,1.0337667027807873,0.53094176987354,"['EGLN2', 'BCL2L2']",0.9999514751263369,0,0,2
280,Estrogen signaling pathway WP712,0.6065034355651238,0.9792896876337185,0.4896888002514213,"['JUN', 'FOS', 'ELK1']",0.9999514751263369,0,0,3
281,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6065034355651238,0.9792896876337185,0.4896888002514213,"['CDKN1A', 'PTH1R', 'MAPK3']",0.9999514751263369,0,0,3
282,Unfolded protein response WP4925,0.6065034355651238,0.9792896876337185,0.4896888002514213,"['XBP1', 'HSPA5', 'DDIT3']",0.9999514751263369,0,0,3
283,Ebola Virus Pathway on Host WP4217,0.6066642471560917,0.9539131892073068,0.47674651982668087,"['VPS18', 'CAV2', 'CLTCL1', 'PIK3CD', 'FLNB', 'ACTB', 'ACTG1', 'CTSB', 'RHOB', 'VAV2', 'HLA-DQB1', 'MAPK3']",0.9999514751263369,0,0,12
284,Bladder cancer WP2828,0.6147603745810304,0.9541131319873185,0.46419771800418547,"['CDKN1A', 'CDKN2A', 'DAPK2', 'HRAS']",0.9999514751263369,0,0,4
285,MAPK Cascade WP422,0.6147603745810304,0.9541131319873185,0.46419771800418547,"['JUN', 'ELK1', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,4
286,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6147603745810304,0.9541131319873185,0.46419771800418547,"['LDHA', 'PKM', 'PGK1', 'BAX']",0.9999514751263369,0,0,4
287,Oxidative Stress WP408,0.6376335905047894,0.9302439024390244,0.4186018212750932,"['NOX4', 'FOS', 'SOD1']",0.9999514751263369,0,0,3
288,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6463617304597206,0.9118764163288755,0.39793920019381385,"['ACAN', 'TIMP3', 'PTH1R', 'CALM1', 'CALM2']",0.9999514751263369,0,0,5
289,Endochondral Ossification WP474,0.6463617304597206,0.9118764163288755,0.39793920019381385,"['ACAN', 'TIMP3', 'PTH1R', 'CALM1', 'CALM2']",0.9999514751263369,0,0,5
290,Cell Differentiation - Index WP2029,0.6488708860182861,1.0337484208626602,0.4471184434897624,['MEF2D'],0.9999514751263369,0,0,1
291,"Cerebral organic acidurias, including diseases WP4519",0.6488708860182861,1.0337484208626602,0.4471184434897624,['MDH2'],0.9999514751263369,0,0,1
292,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.6488708860182861,1.0337484208626602,0.4471184434897624,['DHCR24'],0.9999514751263369,0,0,1
293,Estrogen metabolism WP697,0.6488708860182861,1.0337484208626602,0.4471184434897624,['CYP1B1'],0.9999514751263369,0,0,1
294,Methylation Pathways WP704,0.6488708860182861,1.0337484208626602,0.4471184434897624,['MAT2B'],0.9999514751263369,0,0,1
295,Osteoblast Signaling WP322,0.6488708860182861,1.0337484208626602,0.4471184434897624,['PTH1R'],0.9999514751263369,0,0,1
296,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.6488708860182861,1.0337484208626602,0.4471184434897624,['JUN'],0.9999514751263369,0,0,1
297,Cardiac Hypertrophic Response WP2795,0.6516684460460673,0.907364741399857,0.38855115313977123,"['NFATC2', 'NRG1', 'PRKD1', 'CALM1', 'CALM2', 'MAPK3']",0.9999514751263369,0,0,6
298,Kit receptor signaling pathway WP304,0.6516684460460673,0.907364741399857,0.38855115313977123,"['BAD', 'RPS6', 'MITF', 'FOS', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,6
299,p53 transcriptional gene network WP4963,0.6516684460460673,0.907364741399857,0.38855115313977123,"['CDKN1A', 'SIVA1', 'GADD45A', 'BAX', 'ISG15', 'SLC7A11']",0.9999514751263369,0,0,6
300,DNA damage response WP707,0.6570797334687942,0.9041508238276299,0.37969805522937056,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'H2AFX', 'CYCS', 'BAX']",0.9999514751263369,0,0,7
301,MET in type 1 papillary renal cell carcinoma WP4205,0.6570797334687942,0.9041508238276299,0.37969805522937056,"['CDKN1A', 'JUN', 'BAD', 'RPL11', 'PIK3CD', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,7
302,Vitamin D-sensitive calcium signaling in depression WP4698,0.6668916939964165,0.8858072513170127,0.35886498710798836,"['CALB1', 'GPX4', 'KCNQ3', 'ITPR2']",0.9999514751263369,0,0,4
303,Sphingolipid pathway WP1422,0.6669941811112169,0.8858691444057297,0.3587539328613031,"['CERS4', 'GAL3ST1', 'SERINC1']",0.9999514751263369,0,0,3
304,Corticotropin-releasing hormone signaling pathway WP2355,0.6677629735061568,0.899857917170973,0.36338242247189595,"['NR4A1', 'HSP90AA1', 'STAR', 'PRKCD', 'IL18', 'PRKCQ', 'FOS', 'ELK1', 'MAPK3']",0.9999514751263369,0,0,9
305,Notch Signaling Pathway Netpath WP61,0.6723254580882827,0.8856832635334264,0.3516275419458195,"['PSENEN', 'CDKN1A', 'JAG1', 'HEY1', 'SKP1', 'DLL3']",0.9999514751263369,0,0,6
306,Proteoglycan biosynthesis WP4784,0.6727058459179311,0.8859309704380127,0.35122478507830546,"['XYLT1', 'B3GALT6']",0.9999514751263369,0,0,2
307,Urea cycle and metabolism of amino groups WP497,0.6727058459179311,0.8859309704380127,0.35122478507830546,"['ODC1', 'CKB']",0.9999514751263369,0,0,2
308,Pathways Regulating Hippo Signaling WP4540,0.6843875543673292,0.8854967761982444,0.33580775874570007,"['PRKCH', 'PRKD3', 'PRKAR1A', 'FLT3', 'PRKCD', 'PRKCQ', 'PLCB2', 'CDH18', 'CDH7']",0.9999514751263369,0,0,9
309,p38 MAPK Signaling Pathway WP400,0.6910685469113376,0.8551873737751514,0.3160056404288216,"['DDIT3', 'ELK1', 'HRAS', 'MEF2D']",0.9999514751263369,0,0,4
310,miRNA regulation of DNA damage response WP1530,0.694485436107003,0.8678326996197718,0.3163979927511321,"['CDKN1A', 'CDKN1B', 'GADD45B', 'GADD45A', 'H2AFX', 'CYCS', 'BAX']",0.9999514751263369,0,0,7
311,Glycosylation and related congenital defects WP4521,0.6945760083398567,0.8455284552845529,0.308155956669246,"['DPM3', 'DOLK', 'MGAT2']",0.9999514751263369,0,0,3
312,IL17 signaling pathway WP2112,0.6945760083398567,0.8455284552845529,0.308155956669246,"['CEBPB', 'IL17RE', 'MAPK3']",0.9999514751263369,0,0,3
313,Resistin as a regulator of inflammation WP4481,0.6945760083398567,0.8455284552845529,0.308155956669246,"['PIK3CD', 'PLCB2', 'MAPK3']",0.9999514751263369,0,0,3
314,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.6976481810831664,0.8859927295227783,0.3189931252163883,['JAG1'],0.9999514751263369,0,0,1
315,Biomarkers for urea cycle disorders WP4583,0.6976481810831664,0.8859927295227783,0.3189931252163883,['GOT1'],0.9999514751263369,0,0,1
316,Canonical NF-KB pathway WP4562,0.6976481810831664,0.8859927295227783,0.3189931252163883,['NFKBIE'],0.9999514751263369,0,0,1
317,"Degradation pathway of sphingolipids, including diseases WP4153",0.6976481810831664,0.8859927295227783,0.3189931252163883,['NEU1'],0.9999514751263369,0,0,1
318,Iron metabolism in placenta WP2007,0.6976481810831664,0.8859927295227783,0.3189931252163883,['FTH1'],0.9999514751263369,0,0,1
319,Leptin and adiponectin WP3934,0.6976481810831664,0.8859927295227783,0.3189931252163883,['LEPR'],0.9999514751263369,0,0,1
320,Mitochondrial CII Assembly WP4920,0.6976481810831664,0.8859927295227783,0.3189931252163883,['SDHAF1'],0.9999514751263369,0,0,1
321,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7004920664204038,0.8715844208809136,0.31025985766051667,"['SHC4', 'BAD', 'PDGFD', 'RPS6', 'PIK3CD', 'BAX', 'NRG1', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,9
322,Constitutive Androstane Receptor Pathway WP2875,0.7054871704091411,0.8267966775009028,0.2884418226288987,"['HSP90AA1', 'CYP3A5']",0.9999514751263369,0,0,2
323,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7054871704091411,0.8267966775009028,0.2884418226288987,"['LTBP1', 'MAPK3']",0.9999514751263369,0,0,2
324,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7054871704091411,0.8267966775009028,0.2884418226288987,"['HRAS', 'MAPK3']",0.9999514751263369,0,0,2
325,Purine metabolism and related disorders WP4224,0.7054871704091411,0.8267966775009028,0.2884418226288987,"['PRPS1', 'APRT']",0.9999514751263369,0,0,2
326,Purinergic signaling WP4900,0.7054871704091411,0.8267966775009028,0.2884418226288987,"['P2RY12', 'P2RY14']",0.9999514751263369,0,0,2
327,Vitamin B12 metabolism WP1533,0.7054871704091411,0.8267966775009028,0.2884418226288987,"['CUBN', 'SOD1']",0.9999514751263369,0,0,2
328,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7054871704091411,0.8267966775009028,0.2884418226288987,"['PYGO1', 'FLT3']",0.9999514751263369,0,0,2
329,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7115313601038287,0.8377205203032658,0.2851062720454373,"['CEBPA', 'CDKN1A', 'CEBPB', 'PPARG', 'ACTB']",0.9999514751263369,0,0,5
330,Nephrotic syndrome WP4758,0.7139694522448623,0.8266088214027476,0.2784969949873381,"['CUBN', 'MYO1E', 'TRPC6', 'ARHGDIA']",0.9999514751263369,0,0,4
331,Endothelin Pathways WP2197,0.7203926421386039,0.808695652173913,0.2652189197900074,"['ADCY10', 'CALM1', 'CALM2']",0.9999514751263369,0,0,3
332,Glycerophospholipid Biosynthetic Pathway WP2533,0.7203926421386039,0.808695652173913,0.2652189197900074,"['PTPMT1', 'PIK3CD', 'CDIPT']",0.9999514751263369,0,0,3
333,Nuclear receptors WP170,0.7203926421386039,0.808695652173913,0.2652189197900074,"['NR4A1', 'ROR1', 'PPARG']",0.9999514751263369,0,0,3
334,Oxysterols derived from cholesterol WP4545,0.7203926421386039,0.808695652173913,0.2652189197900074,"['CYP39A1', 'DBP', 'ACOT11']",0.9999514751263369,0,0,3
335,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.7203926421386039,0.808695652173913,0.2652189197900074,"['CDKN1B', 'BAD', 'HRAS']",0.9999514751263369,0,0,3
336,The influence of laminopathies on Wnt signaling WP4844,0.7203926421386039,0.808695652173913,0.2652189197900074,"['CEBPA', 'CEBPB', 'PPARG']",0.9999514751263369,0,0,3
337,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.731263405693582,0.8156038495587857,0.25526895541551486,"['ADCY10', 'CFL1', 'BANF1', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,5
338,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.731263405693582,0.8156038495587857,0.25526895541551486,"['EIF4A2', 'RPS6KA2', 'PRKCD', 'RPS6', 'MAPK3']",0.9999514751263369,0,0,5
339,Immune response to tuberculosis WP4197,0.7354804559416532,0.7750541711809318,0.23812090970686453,"['TAP1', 'IFIT1']",0.9999514751263369,0,0,2
340,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7354804559416532,0.7750541711809318,0.23812090970686453,"['B3GALT1', 'ST6GALNAC3']",0.9999514751263369,0,0,2
341,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7354804559416532,0.7750541711809318,0.23812090970686453,"['MDH2', 'IDH3B']",0.9999514751263369,0,0,2
342,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7355978721599238,0.799874046602757,0.24561866641109328,"['CDKN1A', 'JUN', 'VAV2', 'MAPK3']",0.9999514751263369,0,0,4
343,Biotin Metabolism (including IEMs) WP5031,0.739652676151653,0.7751759610178668,0.2337733489929103,['ACACB'],0.9999514751263369,0,0,1
344,Cancer immunotherapy by CTLA4 blockade WP4582,0.739652676151653,0.7751759610178668,0.2337733489929103,['PIK3CD'],0.9999514751263369,0,0,1
345,Glutathione metabolism WP100,0.739652676151653,0.7751759610178668,0.2337733489929103,['GPX4'],0.9999514751263369,0,0,1
346,miR-509-3p alteration of YAP1/ECM axis WP3967,0.739652676151653,0.7751759610178668,0.2337733489929103,['SPARC'],0.9999514751263369,0,0,1
347,Serotonin and anxiety-related events WP3944,0.739652676151653,0.7751759610178668,0.2337733489929103,['FOS'],0.9999514751263369,0,0,1
348,Thiamine metabolic pathways WP4297,0.739652676151653,0.7751759610178668,0.2337733489929103,['SLC19A3'],0.9999514751263369,0,0,1
349,Intraflagellar transport proteins binding to dynein WP4532,0.7444762113532415,0.7749322493224933,0.22866265291992563,"['DYNLT3', 'DYNLL1', 'DYNLL2']",0.9999514751263369,0,0,3
350,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.7444762113532415,0.7749322493224933,0.22866265291992563,"['ACTA2', 'BAX', 'PRKCQ']",0.9999514751263369,0,0,3
351,3q29 copy number variation syndrome WP4906,0.746832671611849,0.8083840815748478,0.23597872735904632,"['JUN', 'NCBP2', 'DYNLT3', 'MAD2L1BP', 'DYNLL1', 'DYNLL2']",0.9999514751263369,0,0,6
352,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7499970111341256,0.7946213670576123,0.2286014883848272,"['XBP1', 'MAP1LC3A', 'HSPA5', 'PPP1R1A', 'DDIT3']",0.9999514751263369,0,0,5
353,Focal Adhesion WP306,0.7527500268895461,0.8641250476553565,0.24543058987100444,"['VAV3', 'SHC4', 'JUN', 'LAMA2', 'CAV2', 'BAD', 'LAMA4', 'LAMA3', 'PIK3CD', 'ELK1', 'ACTB', 'MYL12B', 'VAV2', 'ACTG1', 'PDGFD', 'FLNB', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,18
354,Angiogenesis WP1539,0.762827535374929,0.7293990185456631,0.19746531525669203,"['TIMP2', 'TIMP3']",0.9999514751263369,0,0,2
355,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.762827535374929,0.7293990185456631,0.19746531525669203,"['H3F3B', 'SUV39H1']",0.9999514751263369,0,0,2
356,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.762827535374929,0.7293990185456631,0.19746531525669203,"['FLT3', 'DNMT3A']",0.9999514751263369,0,0,2
357,Monoamine GPCRs WP58,0.762827535374929,0.7293990185456631,0.19746531525669203,"['CHRM5', 'ADRA1D']",0.9999514751263369,0,0,2
358,Retinoblastoma gene in cancer WP2446,0.7739008835571208,0.7994389901823282,0.2049053835581418,"['CDKN1A', 'CDKN1B', 'TFDP2', 'H2AFZ', 'SUV39H1', 'RPA3', 'STMN1', 'MCM4']",0.9999514751263369,0,0,8
359,Integrated Cancer Pathway WP1971,0.7751028058100295,0.7512653651482285,0.19139206825252056,"['CDKN1A', 'CDKN1B', 'BAD', 'BAX']",0.9999514751263369,0,0,4
360,Alanine and aspartate metabolism WP106,0.7758243446274022,0.6889851410696024,0.17488450888850043,['GOT1'],0.9999514751263369,0,0,1
361,Dopamine metabolism WP2436,0.7758243446274022,0.6889851410696024,0.17488450888850043,['SOD1'],0.9999514751263369,0,0,1
362,ID signaling pathway WP53,0.7758243446274022,0.6889851410696024,0.17488450888850043,['ELK1'],0.9999514751263369,0,0,1
363,Osteoclast Signaling WP12,0.7758243446274022,0.6889851410696024,0.17488450888850043,['ATP6V1G1'],0.9999514751263369,0,0,1
364,Osteopontin Signaling WP1434,0.7758243446274022,0.6889851410696024,0.17488450888850043,['MAPK3'],0.9999514751263369,0,0,1
365,TCA cycle in senescence WP5050,0.7758243446274022,0.6889851410696024,0.17488450888850043,['GOT1'],0.9999514751263369,0,0,1
366,Ciliary landscape WP4352,0.7772427899879848,0.8636780905752754,0.21764904354461448,"['EXOC8', 'NDUFA5', 'SSNA1', 'DYNLT3', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'PSMD8', 'PSMD7', 'EXOSC4', 'ARHGDIA', 'CD2BP2', 'NEFL', 'ANKS6', 'MCM4', 'NEFM', 'TMED1', 'CALM1', 'COPS8', 'DCAF11', 'CALM2']",0.9999514751263369,0,0,24
367,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7791542401405551,0.7745656894679696,0.19328996713358462,"['BAD', 'STMN1', 'BAX', 'HRAS', 'ANGPTL1', 'MAPK3']",0.9999514751263369,0,0,6
368,Regulation of toll-like receptor signaling pathway WP1449,0.7857970513022035,0.7964577021673269,0.19199148476265582,"['JUN', 'CUEDC2', 'TICAM2', 'PELI3', 'PELI2', 'PIK3CD', 'FADD', 'FOS', 'MAPK3']",0.9999514751263369,0,0,9
369,miRNA regulation of prostate cancer signaling pathways WP3981,0.7876434258020689,0.7151969981238274,0.17072453013917546,"['CDKN1A', 'CDKN1B', 'BAD']",0.9999514751263369,0,0,3
370,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7876434258020689,0.7151969981238274,0.17072453013917546,"['TNFSF4', 'RPS6', 'MAPK3']",0.9999514751263369,0,0,3
371,1q21.1 copy number variation syndrome WP4905,0.7876846145481824,0.6888166606476466,0.16439126534656598,"['PYGO1', 'ACP6']",0.9999514751263369,0,0,2
372,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7876846145481824,0.6888166606476466,0.16439126534656598,"['CEBPA', 'CEBPB']",0.9999514751263369,0,0,2
373,NRF2-ARE regulation WP4357,0.7876846145481824,0.6888166606476466,0.16439126534656598,"['CEBPB', 'SLC7A11']",0.9999514751263369,0,0,2
374,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7876846145481824,0.6888166606476466,0.16439126534656598,"['CA8', 'PLCB2']",0.9999514751263369,0,0,2
375,SARS-CoV-2 mitochondrial interactions WP5038,0.7876846145481824,0.6888166606476466,0.16439126534656598,"['NDUFB9', 'PHB']",0.9999514751263369,0,0,2
376,Signal Transduction of S1P Receptor WP26,0.7876846145481824,0.6888166606476466,0.16439126534656598,"['PLCB2', 'MAPK3']",0.9999514751263369,0,0,2
377,Urea cycle and associated pathways WP4595,0.7876846145481824,0.6888166606476466,0.16439126534656598,"['GOT1', 'MDH2']",0.9999514751263369,0,0,2
378,Regulation of Actin Cytoskeleton WP51,0.8063334905886167,0.8100877505885711,0.17437775723630397,"['CHRM5', 'BRK1', 'PIK3CD', 'FGF1', 'ACTB', 'ACTG1', 'FGF17', 'CFL2', 'TMSB4X', 'CFL1', 'PIP4K2C', 'FGF10', 'ARHGEF6', 'MAPK3']",0.9999514751263369,0,0,14
379,BDNF-TrkB Signaling WP3676,0.8068526232262919,0.688647997591087,0.14779367379629346,"['TRPC6', 'BDNF', 'HRAS']",0.9999514751263369,0,0,3
380,Fatty acid beta-oxidation WP143,0.8068526232262919,0.688647997591087,0.14779367379629346,"['TPI1', 'LPL', 'ACSL5']",0.9999514751263369,0,0,3
381,Leptin Insulin Overlap WP3935,0.806972765360651,0.6200324851109908,0.13297548968820536,['LEPR'],0.9999514751263369,0,0,1
382,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.806972765360651,0.6200324851109908,0.13297548968820536,['SOX4'],0.9999514751263369,0,0,1
383,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.806972765360651,0.6200324851109908,0.13297548968820536,['ANAPC11'],0.9999514751263369,0,0,1
384,Toll-like Receptor Signaling Pathway WP75,0.8082598051330931,0.7434527687296417,0.158260077898795,"['JUN', 'TICAM2', 'PIK3CD', 'FADD', 'FOS', 'MAPK3']",0.9999514751263369,0,0,6
385,Differentiation Pathway WP2848,0.810215551665435,0.6525061298967897,0.13732314725870007,"['FGF1', 'FGF10']",0.9999514751263369,0,0,2
386,Fatty Acid Biosynthesis WP357,0.810215551665435,0.6525061298967897,0.13732314725870007,"['ACSL5', 'ACACB']",0.9999514751263369,0,0,2
387,Glycerolipids and Glycerophospholipids WP4722,0.810215551665435,0.6525061298967897,0.13732314725870007,"['DGAT2', 'CDIPT']",0.9999514751263369,0,0,2
388,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.810215551665435,0.6525061298967897,0.13732314725870007,"['ADAMTS2', 'PLOD2']",0.9999514751263369,0,0,2
389,16p11.2 proximal deletion syndrome WP4949,0.8163070425801976,0.7476071850006556,0.15173788082121717,"['TCP1', 'PPARG', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'MAPK3']",0.9999514751263369,0,0,7
390,AMP-activated protein kinase (AMPK) signaling WP1403,0.8216450047920576,0.7288113942645462,0.14317269889925666,"['GYS2', 'CDKN1A', 'LEPR', 'PIK3CD', 'EEF2', 'ACACB']",0.9999514751263369,0,0,6
391,Histone Modifications WP2369,0.8254315656948208,0.6884791516027958,0.132083981325455,"['SET', 'H3F3B', 'SUV39H1', 'HIST1H4C']",0.9999514751263369,0,0,4
392,Gastric Cancer Network 2 WP2363,0.8305867246479186,0.6198266522210184,0.11505403974808023,"['S100A6', 'CACYBP']",0.9999514751263369,0,0,2
393,MTHFR deficiency WP4288,0.8305867246479186,0.6198266522210184,0.11505403974808023,"['DNMT3A', 'CYCS']",0.9999514751263369,0,0,2
394,Cell Differentiation - Index expanded WP2023,0.8337952024897889,0.5636166756903086,0.10244717569201495,['MEF2D'],0.9999514751263369,0,0,1
395,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8337952024897889,0.5636166756903086,0.10244717569201495,['LDHA'],0.9999514751263369,0,0,1
396,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8337952024897889,0.5636166756903086,0.10244717569201495,['DKK3'],0.9999514751263369,0,0,1
397,Serotonin and anxiety WP3947,0.8337952024897889,0.5636166756903086,0.10244717569201495,['FOS'],0.9999514751263369,0,0,1
398,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8337952024897889,0.5636166756903086,0.10244717569201495,['MAPK3'],0.9999514751263369,0,0,1
399,PPAR signaling pathway WP3942,0.8399864474039204,0.6698129800082078,0.11679496869653712,"['FABP7', 'ACSL5', 'LPL', 'PPARG']",0.9999514751263369,0,0,4
400,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8408865162212152,0.6410428931875526,0.11109181490901533,"['MAP1LC3A', 'IGFBP5', 'TNFSF9']",0.9999514751263369,0,0,3
401,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8408865162212152,0.6410428931875526,0.11109181490901533,"['JUN', 'FADD', 'MAPK3']",0.9999514751263369,0,0,3
402,Male infertility WP4673,0.8421270344080422,0.7430342577487765,0.12767141841592955,"['CYP26B1', 'SPATA17', 'MSH4', 'HMGA1', 'AHRR', 'HORMAD1', 'TEX15', 'CLU', 'ETV5']",0.9999514751263369,0,0,9
403,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8422963294119236,0.6883101223850003,0.11813011759779571,"['MYO1E', 'CDKN1A', 'CDKN1B', 'TRPC6', 'JAG1']",0.9999514751263369,0,0,5
404,Thermogenesis WP4321,0.848729607913559,0.7458998125254008,0.12233847909823369,"['ADCY10', 'CREB3', 'RPS6KA2', 'RPS6', 'ZNF516', 'ACSL5', 'PPARG', 'HRAS', 'ACTB', 'ACTG1']",0.9999514751263369,0,0,10
405,Cannabinoid receptor signaling WP3869,0.8489631747578621,0.5902595057524636,0.09664877772242707,"['PRKAR1A', 'MAPK3']",0.9999514751263369,0,0,2
406,Ethanol effects on histone modifications WP3996,0.8489631747578621,0.5902595057524636,0.09664877772242707,"['AHCY', 'ALDH1A1']",0.9999514751263369,0,0,2
407,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8489631747578621,0.5902595057524636,0.09664877772242707,"['LPL', 'NDRG1']",0.9999514751263369,0,0,2
408,AGE/RAGE pathway WP2324,0.8545632275092437,0.6732878812899573,0.10581714550299592,"['JUN', 'PRKCD', 'CYCS', 'MAPK3', 'SOD1']",0.9999514751263369,0,0,5
409,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8558682819156407,0.6196205962059621,0.09643700043956417,"['BDNF', 'GABRD', 'GABRG3']",0.9999514751263369,0,0,3
410,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8558682819156407,0.6196205962059621,0.09643700043956417,"['ACTA2', 'ACTB', 'ACTG1']",0.9999514751263369,0,0,3
411,PI3K-Akt signaling pathway WP4172,0.8567439908855689,0.8109721023871154,0.1253893697122627,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'LAMA2', 'BDNF', 'FLT3', 'BAD', 'LAMA4', 'RPS6', 'LAMA3', 'PIK3CD', 'FGF1', 'HSP90B1', 'GYS2', 'FGF17', 'CREB3', 'GNG10', 'EFNA3', 'GNG3', 'PDGFD', 'COL6A6', 'HRAS', 'FGF10', 'MAPK3']",0.9999514751263369,0,0,24
412,IL-9 signaling pathway WP22,0.8568921800158693,0.5166035011730734,0.07978588713243528,['MAPK3'],0.9999514751263369,0,0,1
413,miRNA targets in ECM and membrane receptors WP2911,0.8568921800158693,0.5166035011730734,0.07978588713243528,['LAMA4'],0.9999514751263369,0,0,1
414,Lung fibrosis WP3624,0.865505771632365,0.5633802816901409,0.08137534413262208,"['CEBPB', 'FGF1']",0.9999514751263369,0,0,2
415,Neovascularisation processes WP4331,0.865505771632365,0.5633802816901409,0.08137534413262208,"['JAG1', 'MAPK3']",0.9999514751263369,0,0,2
416,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8660239016889535,0.658904884496831,0.09477870421237763,"['LAMA2', 'CTNNA2', 'ACTB', 'SGCG', 'ACTG1']",0.9999514751263369,0,0,5
417,Amino Acid metabolism WP3925,0.8708299238027222,0.6879715130665701,0.09515236761759129,"['LDHA', 'PKM', 'TDO2', 'GOT1', 'MDH2', 'ALDH1A1', 'ODC1']",0.9999514751263369,0,0,7
418,NAD+ metabolism WP3644,0.8767808973313498,0.47682312273541294,0.0627013584351406,['NMNAT1'],0.9999514751263369,0,0,1
419,Pyrimidine metabolism and related diseases WP4225,0.8767808973313498,0.47682312273541294,0.0627013584351406,['NT5C'],0.9999514751263369,0,0,1
420,Riboflavin and CoQ disorders WP5037,0.8767808973313498,0.47682312273541294,0.0627013584351406,['RFK'],0.9999514751263369,0,0,1
421,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8767808973313498,0.47682312273541294,0.0627013584351406,['NFKBIE'],0.9999514751263369,0,0,1
422,RANKL/RANK signaling pathway WP2018,0.8776507519255926,0.61941431670282,0.08083762012400018,"['JUN', 'MITF', 'FOS', 'MAPK3']",0.9999514751263369,0,0,4
423,IL-6 signaling pathway WP364,0.882163100649808,0.5807926829268293,0.07281881009835547,"['BAD', 'PRKCD', 'MAPK3']",0.9999514751263369,0,0,3
424,DNA Repair Pathways Full Network WP4946,0.883649349054813,0.727925156990901,0.09004067245022139,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'CENPX', 'CETN2', 'RPA3', 'APEX1', 'H2AFX', 'POLD2', 'POLE3', 'FANCF']",0.9999514751263369,0,0,12
425,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8849743084882279,0.7854779383940059,0.09598278399413925,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'LAMA2', 'BAD', 'LAMA4', 'RPS6', 'LAMA3', 'PIK3CD', 'HIF3A', 'FGF1', 'HSP90B1', 'GYS2', 'FGF17', 'CREB3', 'GNG10', 'EFNA3', 'GNG3', 'PDGFD', 'PELO', 'HRAS', 'FGF10', 'MAPK3']",0.9999514751263369,0,0,23
426,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8883736162498616,0.6042537431881911,0.07152121659115904,"['BDNF', 'PIK3CD', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,4
427,Wnt Signaling Pathway WP363,0.8883736162498616,0.6042537431881911,0.07152121659115904,"['GSK3A', 'NFATC2', 'PPARG', 'ROR1']",0.9999514751263369,0,0,4
428,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8936353565261631,0.5631436314363144,0.06332970557126368,"['CXCL17', 'FADD', 'IFIT2']",0.9999514751263369,0,0,3
429,Nanoparticle-mediated activation of receptor signaling WP2643,0.8937005305428457,0.5163416395810762,0.058028816070971816,"['PIK3CD', 'HRAS']",0.9999514751263369,0,0,2
430,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.8939067854840671,0.4427256555031325,0.049653354014960224,['MAPK3'],0.9999514751263369,0,0,1
431,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8939067854840671,0.4427256555031325,0.049653354014960224,['PPARG'],0.9999514751263369,0,0,1
432,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8939067854840671,0.4427256555031325,0.049653354014960224,['SUV39H1'],0.9999514751263369,0,0,1
433,Endoderm differentiation WP2853,0.9032138722141445,0.6874622173860476,0.06998084015534639,"['VAV3', 'DUSP4', 'TOX3', 'DAB2', 'DUSP2', 'TRIM5', 'TCEAL2', 'PLCH1', 'TOX', 'NME1']",0.9999514751263369,0,0,10
434,Interleukin-11 Signaling Pathway WP2332,0.9040940798887005,0.5465327594452415,0.05510244571370065,"['RPS6', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,3
435,One-carbon metabolism and related pathways WP3940,0.9040940798887005,0.5465327594452415,0.05510244571370065,"['GPX4', 'DNMT3A', 'SOD1']",0.9999514751263369,0,0,3
436,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.905638437534015,0.49564463705308776,0.04912588172359361,"['JUN', 'FOS']",0.9999514751263369,0,0,2
437,TGF-beta Signaling Pathway WP366,0.905990569106775,0.6943663693022118,0.06855227967904075,"['KLF10', 'JUN', 'DAB2', 'CDKN1A', 'PARD6A', 'CITED1', 'SUMO1', 'LIMK2', 'NEDD9', 'FOS', 'SKP1']",0.9999514751263369,0,0,11
438,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9086534614977272,0.41317451723515614,0.03957860179600985,['PTGES'],0.9999514751263369,0,0,1
439,Kallmann's Syndrome WP5074,0.9086534614977272,0.41317451723515614,0.03957860179600985,['PRKCQ'],0.9999514751263369,0,0,1
440,Statin inhibition of cholesterol production WP430,0.9086534614977272,0.41317451723515614,0.03957860179600985,['LPL'],0.9999514751263369,0,0,1
441,Autophagy WP4923,0.916312613249828,0.47653971164263687,0.04164847079649091,"['ATG101', 'ATG9A']",0.9999514751263369,0,0,2
442,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.916312613249828,0.47653971164263687,0.04164847079649091,"['SUPT4H1', 'NFATC2']",0.9999514751263369,0,0,2
443,Tumor suppressor activity of SMARCB1 WP4204,0.916312613249828,0.47653971164263687,0.04164847079649091,"['H3F3B', 'CDKN2A']",0.9999514751263369,0,0,2
444,DNA damage response (only ATM dependent) WP710,0.9183807684414715,0.6428571428571429,0.05473491037839006,"['JUN', 'CDKN1A', 'CDKN1B', 'CDKN2A', 'BAD', 'PIK3CD', 'BAX', 'HRAS']",0.9999514751263369,0,0,8
445,Ebstein-Barr virus LMP1 signaling WP262,0.9213513019864951,0.3873172712506768,0.0317266605074942,['HSP90AA1'],0.9999514751263369,0,0,1
446,Hippo-Yap signaling pathway WP4537,0.9213513019864951,0.3873172712506768,0.0317266605074942,['NDRG1'],0.9999514751263369,0,0,1
447,Regulation of Microtubule Cytoskeleton WP2038,0.9222650354153961,0.5160794941282746,0.041762514942776975,"['PARD6A', 'CFL2', 'STMN1']",0.9999514751263369,0,0,3
448,Insulin Signaling WP481,0.9223425345153132,0.7078247398208418,0.05721956945663696,"['EGR1', 'XBP1', 'JUN', 'GSK3A', 'PRKCH', 'PRKCD', 'PIK3CD', 'FOS', 'ELK1', 'GYS2', 'RPS6KA2', 'PRKCQ', 'HRAS', 'ARF6', 'MAPK3']",0.9999514751263369,0,0,15
449,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9234495451712589,0.550349481802844,0.043829345777379375,"['KAT5', 'CDKN2A', 'H2AFX', 'BAX']",0.9999514751263369,0,0,4
450,ESC Pluripotency Pathways WP3931,0.9242537601945124,0.6345596432552955,0.04998338283798192,"['FGF17', 'JUN', 'PIK3CD', 'FOS', 'FGF1', 'ELK1', 'HRAS', 'FGF10']",0.9999514751263369,0,0,8
451,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9247544955303063,0.5989282336870863,0.046852351111491955,"['PIK3CD', 'NRG1', 'CALM1', 'PLCB2', 'CALM2', 'MAPK3']",0.9999514751263369,0,0,6
452,Head and Neck Squamous Cell Carcinoma WP4674,0.9266898478158007,0.573139607323004,0.043636755248785165,"['CDKN1A', 'CDKN2A', 'RPS6', 'FADD', 'HRAS']",0.9999514751263369,0,0,5
453,MAPK Signaling Pathway WP382,0.9267187940515998,0.7370689655172413,0.05609471467912075,"['DUSP4', 'HSPA8', 'JUN', 'DUSP2', 'DUSP3', 'GADD45A', 'BDNF', 'PRKCD', 'FOS', 'FGF1', 'ELK1', 'DUSP6', 'DUSP7', 'FGF17', 'NR4A1', 'DDIT3', 'STMN1', 'FLNB', 'HRAS', 'FGF10', 'MAPK3']",0.9999514751263369,0,0,21
454,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9301163672907425,0.5020874533069655,0.03637401402584425,"['MAP1LC3A', 'ATG101', 'FTL']",0.9999514751263369,0,0,3
455,Joubert Syndrome WP4656,0.9308132806305787,0.5893697326922083,0.04225579400176012,"['TMEM17', 'KAT5', 'CETN2', 'ANKS6', 'ARL2', 'ZNF423']",0.9999514751263369,0,0,6
456,Chemokine signaling pathway WP3929,0.9311740629779336,0.6509936429757746,0.046421741963015066,"['SHC4', 'VAV3', 'GNG10', 'GNG3', 'PRKCD', 'PIK3CD', 'HRAS', 'PLCB2', 'VAV2', 'MAPK3']",0.9999514751263369,0,0,10
457,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9311740629779336,0.6509936429757746,0.046421741963015066,"['CLDN4', 'SPARC', 'JAG1', 'EIF5A2', 'PIK3CD', 'WNT9A', 'HRAS', 'MEF2D', 'DLL3', 'MAPK3']",0.9999514751263369,0,0,10
458,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9322848293603351,0.36450205420554793,0.025557754115288257,['MAP1LC3A'],0.9999514751263369,0,0,1
459,Monoamine Transport WP727,0.9322848293603351,0.36450205420554793,0.025557754115288257,['TDO2'],0.9999514751263369,0,0,1
460,Toll-like Receptor Signaling related to MyD88 WP3858,0.9322848293603351,0.36450205420554793,0.025557754115288257,['TICAM2'],0.9999514751263369,0,0,1
461,ATM Signaling Network in Development and Disease  WP3878,0.9372318570687498,0.4888318356867779,0.031688319013650906,"['KAT5', 'H2AFX', 'CDK5R1']",0.9999514751263369,0,0,3
462,Mesodermal commitment pathway WP2857,0.9397661793654615,0.6253826273438788,0.03885138292013828,"['VAV3', 'TOX3', 'ARL4A', 'PRKAR1A', 'TRIM5', 'BHLHE40', 'RPL38', 'PLCH1', 'TOX']",0.9999514751263369,0,0,9
463,Ras signaling WP4223,0.9409105053605182,0.6759303435114504,0.04116905828398591,"['SHC4', 'FLT3', 'BAD', 'PIK3CD', 'ELK1', 'ETS2', 'GNG10', 'GNG3', 'CALM3', 'CALM1', 'CALM2', 'HRAS', 'ARF6', 'MAPK3']",0.9999514751263369,0,0,14
464,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9416990725492291,0.3442218612765445,0.020677238997780317,['FGF1'],0.9999514751263369,0,0,1
465,Energy Metabolism WP1541,0.9436721231039136,0.4762559933291641,0.027611655782576783,"['UCP3', 'PPARG', 'MEF2D']",0.9999514751263369,0,0,3
466,Disruption of postsynaptic signaling by CNV WP4875,0.9486482169400715,0.412856626941134,0.02176466075265969,"['YWHAG', 'MAPK3']",0.9999514751263369,0,0,2
467,EPO Receptor Signaling WP581,0.9498050467867756,0.32607642549796256,0.01679245637063131,['MAPK3'],0.9999514751263369,0,0,1
468,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9498050467867756,0.32607642549796256,0.01679245637063131,['TICAM2'],0.9999514751263369,0,0,1
469,Neural Crest Differentiation WP2064,0.9532122086638322,0.49509761388286333,0.02372395168523147,"['MITF', 'CDH7', 'RHOB', 'DLL3']",0.9999514751263369,0,0,4
470,Notch Signaling WP268,0.9546339833416762,0.39950372208436724,0.01854786936137887,"['JAG1', 'DLL3']",0.9999514751263369,0,0,2
471,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9547508593919399,0.4529446757882213,0.020973536518278577,"['FOS', 'ELK1', 'MAPK3']",0.9999514751263369,0,0,3
472,Integrated breast cancer pathway WP1984,0.9558290984876643,0.6337634769007318,0.028630993379728274,"['PLK3', 'JUN', 'GSK3A', 'ANXA1', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'PHB', 'FADD', 'FAU', 'JAKMIP1']",0.9999514751263369,0,0,12
473,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9567844727407037,0.30974553329723875,0.013683666907348109,['HRAS'],0.9999514751263369,0,0,1
474,miRNA regulation of p53 pathway in prostate cancer WP3982,0.9567844727407037,0.30974553329723875,0.013683666907348109,['BAX'],0.9999514751263369,0,0,1
475,Sphingolipid Metabolism (general overview) WP4725,0.9567844727407037,0.30974553329723875,0.013683666907348109,['CERS4'],0.9999514751263369,0,0,1
476,Wnt signaling pathway and pluripotency WP399,0.9588830182421679,0.5378369447198225,0.022581726625512267,"['JUN', 'PRKCH', 'PRKCD', 'PRKCQ', 'PPM1J', 'PRKD1']",0.9999514751263369,0,0,6
477,Nanoparticle triggered autophagic cell death WP2509,0.9627938416503772,0.29496996416325055,0.011184072130811473,['MAP1LC3A'],0.9999514751263369,0,0,1
478,Sphingolipid Metabolism (integrated pathway) WP4726,0.9627938416503772,0.29496996416325055,0.011184072130811473,['CERS4'],0.9999514751263369,0,0,1
479,Netrin-UNC5B signaling pathway WP4747,0.9646627822661992,0.37522571325388226,0.01349937809385292,"['JUN', 'MAPK3']",0.9999514751263369,0,0,2
480,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9676082527459361,0.4219512195121951,0.013893997601470764,"['TKFC', 'ISG15', 'FADD']",0.9999514751263369,0,0,3
481,Signal transduction through IL1R WP4496,0.9679679163595367,0.2815376285868977,0.00916583377693037,['JUN'],0.9999514751263369,0,0,1
482,Fragile X Syndrome  WP4549,0.9693117513534854,0.582873098322623,0.018167568110619384,"['GRIP1', 'DUSP3', 'PRKAR1A', 'BDNF', 'CDKN2A', 'CLTCL1', 'AP2S1', 'AKAP5', 'GABRD', 'AP2M1']",0.9999514751263369,0,0,10
483,IL-1 signaling pathway WP195,0.9710651201101634,0.4125383920505872,0.012112848284839038,"['JUN', 'PELI2', 'MAPK3']",0.9999514751263369,0,0,3
484,MECP2 and Associated Rett Syndrome WP3584,0.9772759106303439,0.43402975986604253,0.009976721272957107,"['BDNF', 'RPS6', 'TAP1', 'FKBP5']",0.9999514751263369,0,0,4
485,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9794567244558147,0.3866531165311653,0.008025845285787871,"['JUN', 'FRAT2', 'ROR1']",0.9999514751263369,0,0,3
486,Lipid Metabolism Pathway WP3965,0.9795605341887277,0.24768814293448835,0.005115067878265529,['PRKAR1A'],0.9999514751263369,0,0,1
487,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.983493351564086,0.41221981200289226,0.006861151913523381,"['GSK3A', 'RBP4', 'LPL', 'PPARG']",0.9999514751263369,0,0,4
488,Splicing factor NOVA regulated synaptic proteins WP4148,0.9835244412629512,0.3173319998888796,0.005271769922748731,"['CAV2', 'NCDN']",0.9999514751263369,0,0,2
489,Pathways affected in adenoid cystic carcinoma WP3651,0.9837007382626677,0.3711219512195122,0.006098853356303644,"['CEBPA', 'CNTN6', 'HRAS']",0.9999514751263369,0,0,3
490,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9837007382626677,0.3711219512195122,0.006098853356303644,"['DUSP2', 'STMN1', 'MAPK3']",0.9999514751263369,0,0,3
491,Wnt signaling WP428,0.9856523920465865,0.43525941323469847,0.006290164512058152,"['JUN', 'FRAT2', 'NFATC2', 'ROR1', 'PLCB2']",0.9999514751263369,0,0,5
492,mRNA Processing WP411,0.986144426550357,0.5321563918802297,0.007424889640431725,"['SF3B5', 'LSM7', 'SF3A1', 'NCBP2', 'CD2BP2', 'SRSF3', 'CSTF2T', 'SNRPE', 'SNU13', 'SRSF9']",0.9999514751263369,0,0,10
493,Ectoderm Differentiation WP2858,0.9876518769188407,0.494,0.006137947342918649,"['TOX3', 'PPFIBP2', 'ARHGDIG', 'SPRY2', 'CTNNA2', 'JAKMIP1', 'CELSR2', 'LY6E']",0.9999514751263369,0,0,8
494,Interferon type I signaling pathways WP585,0.9888229182818596,0.29458804106691433,0.0033111739041603644,"['RPS6', 'PIK3CD']",0.9999514751263369,0,0,2
495,Hippo-Merlin Signaling Dysregulation WP4541,0.9894492573330284,0.41750377615814405,0.004428377538733281,"['PRKAR1A', 'FLT3', 'HRAS', 'CDH18', 'CDH7']",0.9999514751263369,0,0,5
496,Target Of Rapamycin (TOR) Signaling WP1471,0.9903350707041333,0.20631654935932142,0.002003733506838726,['RRAGA'],0.9999514751263369,0,0,1
497,Integrin-mediated Cell Adhesion WP185,0.9904872373972083,0.4119008862362091,0.003937071391132949,"['VAV3', 'CAPNS1', 'CAV2', 'HRAS', 'VAV2']",0.9999514751263369,0,0,5
498,Hedgehog Signaling Pathway WP4249,0.9916797716748085,0.1996437116859074,0.001668030123514797,['EVC'],0.9999514751263369,0,0,1
499,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9919650192750878,0.331184668989547,0.002671810838603075,"['JUN', 'FRAT2', 'ROR1']",0.9999514751263369,0,0,3
500,Allograft Rejection WP2328,0.9928374172830658,0.19338792636708174,0.0013901414852851323,['HLA-DQB1'],0.9999514751263369,0,0,1
501,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9981400132058831,0.15081807017312188,0.00028078082417203813,['DHCR24'],0.9999514751263369,0,0,1
502,Rett syndrome causing genes WP4312,0.9991199898035867,0.13436595183729197,0.00011829546591322524,['GABRD'],0.9999514751263369,0,0,1
503,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9991656373139486,0.3424417903245265,0.00028583991566080713,"['GSK3A', 'RPS6KA2', 'LPL', 'PIK3CD', 'HRAS', 'MAPK3']",0.9999514751263369,0,0,6
504,Ciliopathies WP4803,0.9992720216061056,0.4130912649436578,0.0003008310281201759,"['DNAH11', 'TMEM17', 'EVC', 'ANKS6', 'PKD1L1', 'CCDC65', 'CFAP410', 'CCNQ', 'ZNF423', 'CCNO']",0.9999514751263369,0,0,10
505,DNA IR-damage and cellular response via ATR WP4016,0.9996981391973886,0.17889051140735157,5.400818524022446e-05,"['FEN1', 'H2AFX']",0.9999514751263369,0,0,2
506,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999514751263369,0.19051211130668008,9.244800435654635e-06,"['TMEM17', 'EVC', 'DYNLL1']",0.9999514751263369,0,0,3
